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The human coat protein II (COPII) secretion system is an essential membrane trafficking 
system that exports cargo from the endoplasmic reticulum. While significant insight into the 
COPII secretion system has been gained using yeast as a model organism, many questions 
about the COPII secretion system in higher eukaryotes remain unanswered: do human COPII 
proteins sculpt membranes like their yeast counterparts? Is cargo exported from the human 
endoplasmic reticulum via COPII carriers? What membrane morphologies do human COPII 
proteins generate, and how are those morphologies regulated to accommodate the wide 
range of cargoes exported from the endoplasmic reticulum? To assess whether human COPII 
proteins are capable of remodelling membranes, I established a minimal in vitro 
reconstitution system using purified proteins and model membranes. I purified human COPII 
proteins as expressed in Escherichia coli and insect cells and established that they were 
capable of membrane binding using liposome flotation assays. Furthermore, I used guanosine 
triphosphate (GTP) hydrolysis assays to characterize the enzymatic activity of the Sar1 
GTPase, the initiating factor of COPII assembly. I observed that Sar1 has an intrinsic GTP 
hydrolysis activity, which is stimulated by other COPII components, indicating that the 
purified components have retained their biologically relevant functionality. Finally, I analysed 
human COPII assemblies on membranes using electron microscopy. This study established 
that human COPII components deform membranes, similarly to yeast COPII. Furthermore, 
they generate a range of diverse membrane morphologies. This suggests that the human 
COPII system can form a range of carriers to accommodate cargo exported from the human 
ER. Using cryo-electron microscopy, I observed that human COPII components form two 
discernible layers on membranes. The establishment of this in vitro reconstitution platform 
allows us to address outstanding questions about the functioning of this complex system, 
such as the importance of different COPII component paralogues in humans and the role of 
GTP hydrolysis in COPII-mediated membrane deformation. Furthermore, it is the first step to 
the structural analysis of human COPII assembled on membranes, which can provide insight 
into global COPII arrangement.  
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I. Introduction: COPII 
Trafficking in Mammals 
 
I.1. Membrane Trafficking in Mammals  
The intracellular organisation of proteins, lipids, and carbohydrates defines cell identity and 
lays the foundation for performing cellular functions. Intracellular trafficking is central to the 
proper distribution of biomolecules. In eukaryotic cells, where the intracellular environment 
is separated into membrane-bound compartments, a gentle balance is maintained between 
the preservation of organelle identities and efficient exchange between compartments. The 
secretory pathway traffics transmembrane and secreted proteins from the endoplasmic 
reticulum (ER) to the Golgi apparatus, their final intramembrane cellular location, or the cell 
surface (Zanetti et al., 2012).  
A range of different and complementary models have been established to encompass the 
diverse mechanisms of intracellular membrane trafficking. These include the fused 
compartments, kiss-and-run, and vesicular transport models, in which membranes bud from 
the originating compartment and fuse transiently or permanently with the acceptor 
membrane (Watson and Stephens, 2005).  
In the vesicular transport model, cargo is transported between specific compartments in 
dedicated vesicles. Cargo in the donor compartment is recognised by the transport machinery 
either directly or through additional receptors. Cytoplasmic transport components are 
recruited to the nascent membrane, coating it and budding it into carriers (Bonifacino and 
Glick, 2004). The resulting cargo-loaded vesicles are then trafficked to the target 
compartment and fuse with the acceptor membrane to release their cargo (Watson and 
Stephens, 2005).  
I.1.1. Mammalian Vesicular Trafficking 
Although the basic foundations of the secretory pathway are conserved throughout the 
eukaryotic kingdom, the mammalian cell has more elaborate needs and more sophisticated 
responses to the environment than the simplest eukaryotic cells. This is reflected in the high 
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level of organisation of the mammalian secretory pathway and the plethora of components 
involved. Early secretion in mammals progresses through three membrane-bound 
compartments: the ER, the endoplasmic reticulum-Golgi intermediate compartment (ERGIC), 
and the Golgi apparatus. The ERGIC is absent in simpler eukaryotic organisms such as yeast, 
where vesicular trafficking progresses directly from the ER to the Golgi apparatus (Barlowe et 
al. 1994). In mammals, anterograde (i.e., forward) transport originates at the ER and proceeds 
in the direction of the ERGIC and the Golgi, while retrograde transport brings cargo back from 
the Golgi towards the ERGIC and the ER. The bi-directionality of traffic is essential for the 
recycling of the components of the transport machinery (Lippincott-Schwartz, 1993). 
Compared to yeast, the complexity of the mammalian cell and the large repertoire of 
trafficked cargo necessitate the involvement of a greater number of coat protein (COP), SNAP 
Receptor (SNARE), and Rab proteins (Bock et al., 2001). The range of different subunits allows 
for cargo binding specificity and the accommodation of a fascinating range of molecules of 
different shapes, sizes, and surface charges (Wendeler, Paccaud and Hauri, 2007).  
I.1.2. Coat complexes 
Four major cytoplasmic coat protein complexes are known to mediate vesicular transport in 
eukaryotic cells: coat protein complexes I and II (COPI and COPII), clathrin, and retromer (Fig.  
1.1) (Lee and Goldberg 2010). Their components are recruited to the membranes of specific 
intracellular compartments to mediate different steps of vesicle trafficking (Barlowe et al. 
1994). COPI and COPII mediate trafficking events between the ER and the Golgi. In yeast, 
COPII is responsible for anterograde trafficking from the ER to the Golgi, while COPI mediates 
intra-Golgi transport and retrograde trafficking from the Golgi to the ER. In mammalian cells, 
COPII vesicles transport cargo to the additional compartment between the ER and the Golgi, 
the ERGIC. The mechanism of transport from the ERGIC to the Golgi is a matter of debate, as 
discussed in Section I.1.2.3. COPI is responsible for retrograde transport from the Golgi 
apparatus and the ERGIC, and between Golgi cisternae (Orci, Glick and Rothman, 1986; Ishii 
et al., 2016). Clathrin, the first discovered and thoroughly characterised vesicle transport 
system, is responsible for endocytic transport from the plasma membrane and transport from 
the trans-Golgi to the endosomal network (Robinson, 1994). Retromer forms a coat that 
traffics cargo from the endosome to the trans-Golgi network and the plasma membrane (PM) 
(Seaman et al., 1997; Temkin et al., 2011; Kovtun et al., 2018). 
 
   
 
 




Figure 1.1: Coat complexes in the mammalian cell. In anterograde trafficking, COPII-coated 
vesicles transport cargo from the ER to the ERGIC. COPI carriers mediate retrograde trafficking 
from the cis-Golgi. The mechanism of cargo transport between the ERGIC and the cis-Golgi is 
unclear. Adapted from Markova and Zanetti, 2019. (Markova and Zanetti, 2019). 
 
I.1.3. The Early Secretory Pathway  
I.1.3.1. ER and ER-exit sites 
The endoplasmic reticulum is a complex and multifunctional intracellular compartment. A 
third of the proteome is translated by ribosomes associated with the ER membrane and 
translocated into the ER lumen. This includes both locally resident proteins and proteins that 
are destined for other cellular compartments, the cell membrane, or secretion. Correctly 
folded proteins destined for anterograde transport are recognised by the transport 
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machinery and its adaptors. They are packaged into coated membrane carriers and released 
in the direction of the Golgi apparatus (Alberts et al., 2002).  
In eukaryotic cells, vesicles are formed and secreted from well-defined and specialised ER and 
ER-proximal loci. Those ER exit sites (ERES) are organised in clusters and are characterised by 
membrane extensions 200-500nm in length and a high local curvature (Okamoto et al., 2012). 
ERES have a high abundance of COPII proteins, recruited through interactions with ERES-
resident proteins (Watson et al., 2006). Furthermore, COPII proteins bind more strongly to 
curved membranes, hence ERES also concentrate COPII through their high curvature 
(Bannykh, Rowe and Balch, 1996; Fan, Roth and Zuber, 2003; Watson and Stephens, 2005). 
ERES serve as assembly platforms for COPII components and mark the budding-prone regions 
of the ER membrane, also expanding beyond it in the direction of the subsequent 
compartment, the ERGIC.  
The abundance, distribution, and morphology of the ERES are organism and cell-line specific. 
There is an interesting link between the position of ERES and the compartment to which COPII 
vesicles are destined (Langhans et al., 2012). In Pichia pastoris, ERES are positioned directly 
opposite the Golgi (Rossanese et al., 1999). In mammalian cells, ERES are concentrated 
opposite the ERGIC, although they are also present in the peripheral ER (Langhans et al., 
2012). An example of structure reflecting function, this arrangement minimises secretory 
pathway cargo transport trajectory. 
I.1.3.2. The ER-to-Golgi intermediate compartment  
Opposite the ERES lies the ERGIC, also referred to as the vesicular tubular clusters (VTCs). The 
ERGIC had previously been classified as a sub-compartment of the ER or the cis-Golgi 
apparatus (Mellman and Simons, 1992; Sitia and Meldolesi, 1992). This was partially informed 
by the absence of ERGIC in yeast, where anterograde intracellular transport progresses 
directly from the ER to the Golgi apparatus. The ERGIC as a self-standing compartment was 
first identified and is still marked by the presence of the lectin ERGIC-53 (Schweizer et al., 
1988; Hauri and Schweizer, 1992; Bannykh, Rowe and Balch, 1996; Klumperman et al., 1998). 
Subsequently, biochemical analysis established that the membrane composition of the ERGIC 
differs from those of both the ER and the Golgi (Appenzeller-Herzog, 2006). Two views of the 
ERGIC have been proposed to delineate its place in vesicular transport, which describe the 
ERGIC as either a dynamic, or a static entity. 
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The dynamic, or transport complex, model describes the ERGIC as a mobile compartment that 
plays an active role in transport to the Golgi apparatus. In this view, the ERGIC is a fusion of 
ER-derived COPII vesicles that migrates towards the Golgi via microtubules to fuse with or 
form part of the cis-Golgi apparatus. In contrast, in the stable compartment model the ERGIC 
is viewed as a static entity. According to this model, COPII vesicles reach the ERGIC and fuse 
with it to release their cargo, which is subsequently incorporated in COPI coated vesicles for 
ERGIC-Golgi transport via microtubules (Ben-Tekaya, 2005).  
In support of the dynamic model, it was observed that when the transport of a model cargo, 
vesicular stomatitis virus G protein (VSVG), fused to green fluorescent protein (GFP), was 
tracked by fluorescence microscopy, large concentrated flexible structures travelled to the 
Golgi via microtubules (Presley et al., 1997). While not rejecting the presence of a static ERGIC 
per se, the study raises questions about its size, structure, and complexity. Fluorescent 
microscopy visualisation of GFP-fused ERGIC-53 paints a more complicated picture: while the 
majority of ERGIC remains stable and shows an extremely wide distribution pattern, a small 
mobile population shows movement between individual stable ERGIC compartments (Ben-
Tekaya, 2005). It has been observed that COPII vesicles can fuse to form a larger membrane 
compartment, which was suggested to bear resemblance to the ERGIC (Xu and Hay, 2004).  
The COPII coat dissociates prior to or simultaneously with carrier fusion with the ERGIC and 
is not observed on carriers between the ERGIC and the Golgi (Stephens, 2003). Further studies 
are needed to capture the nature of this complex and flexible membrane-bound 
compartment and to establish the role of COPII vesicles in its formation.  
I.2. COPII Vesicle Formation  
Important knowledge of the mechanism of COPII vesicle formation has been gained from 
genetic screens and reconstitutions of COPII vesicles in vitro. Historically, the majority of 
membrane trafficking studies have used Saccharomyces cerevisiae as a model organism, as 
the yeast genome was by far the best studied and most easily manipulated in the eukaryotic 
kingdom (Botstein and Fink 1988; Botstein and Fink 2011). Light was shed on this vesicular 
transport system through genetic screens in yeast, in which a plethora of genes involved in 
protein secretion and transport were discovered (Cooper GM, 2000). Further advances in the 
understanding of COPII trafficking were gained from biochemical reconstitutions of COPII 
budding using purified proteins and a membrane source (Barlowe et al., 1994; Rowe et al., 
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1996; Aridor et al., 1998; Kim et al., 2005; Boyadjiev et al., 2006; Fromme et al., 2007; Bacia 
et al., 2011; Zanetti et al., 2013; Gorur et al., 2017; Hutchings et al., 2018). In these studies, 
the proteins that were used were almost invariably from yeast. This foundational work has 
helped build a thorough understanding of the molecular mechanisms of COPII assembly, as 
described below. In vitro reconstitutions with mammalian COPII proteins are discussed in 
Section I.7.  
In COPII vesicle formation, the cytoplasmic COPII proteins are sequentially assembled on the 
ER membrane. They induce and support membrane curvature, recognise cargo, and bud the 
membrane into cargo carriers (Fig.1.2). Briefly, Sar1 is recruited to specific ER sites and 
associates with the membrane exchanging guanine nucleoside diphosphate (GDP) for guanine 
nucleoside triphosphate (GTP). It then recruits Sec23/24, cytoplasmic heterodimers forming 
the COPII inner coat, which in turn recruit Sec13/31 heterotetramers that form the outer coat. 
This completes the COPII coat assembly, resulting in vesicle scission. Assemblies are short-
lived due to an intrinsic propensity for disassembly. GTP hydrolysis by Sar1, stimulated by the 
specific GTPase activating protein (GAP) activity of Sec23/24, and in turn accelerated by 
Sec13/31, results in the shedding of Sar1 from the membrane and eventually in the 
dissociation of the COPII coat (Zanetti et al., 2012) .  
 
 
   
 
 




Figure 1.2: COPII assembly at ERES. (1) The Sar1 GTPase is activated by Sec12, which 
stimulates Sar1 to exchange GDP for GTP. Sar1 inserts an N-terminal helix into the membrane. 
(2) Inner coat components are recruited that bind Sar1 and cargo/cargo adapters. (3) The 
outer coat is recruited to Sar1-Sec23/24 complexes. (4) COPII components bend the ER 
membrane. (5) A membrane bud is formed. (6) A nascent COPII vesicle forms by scission from 
ERES.  
 
I.2.1. Sar1 is activated 
To promote membrane budding, the Sar1 GTPase requires GTP. Its exchange from GDP to 
GTP is facilitated by a Sar1-specific ER-localised guanine nucleotide exchange factor (GEF), 
Sec12 (Nakano, Brada and Schekman, 1988; Barlowe et al., 1994; Weissman, Plutner and 
Balch, 2001; Bielli et al., 2005). Sec12 is a transmembrane ER-resident protein with a 
prominent solenoid-fold cytoplasmic domain that binds Sar1 when stabilised by a potassium 
ion (McMahon et al., 2012). Sar1 possesses an N-terminal helix that is essential for interaction 
with Sec12, as a 25-residue-amino-terminal truncation of Sar1 is incapable of Sec12 binding  
(Huang et al., 2001). Sar1-GTP distribution and subsequent COPII vesicle formation is thereby 
spatially limited to the ER by Sec12 (Barlowe, 2003).  
GTP binding introduces a conformational change in Sar1, which exposes its amphipathic N-
terminal 25-residue helix that inserts into the outer leaflet of the ER membrane (Goldberg, 
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1998; Huang et al., 2001; Bi, Corpina and Goldberg, 2002; Bielli et al., 2005; Rao et al., 2006; 
Hutchings et al., 2018). Membrane curvature has been proposed to be a result of the 
asymmetric insertion of Sar1 into the outer, but not the inner membrane leaflet. This 
mechanism is termed ‘bilayer coupling’ and is based on the difference in composition 
between the two membrane leaflets. This asymmetry gives rise to membrane fluidity and an 
expansion of the outer membrane layer as compared to the inner layer, resulting in curvature 
induction (Sheetz and Singer, 1974; Huttner and Zimmerberg, 2001; Zimmerberg and 
McLaughlin, 2004). However, the insertion of amphipathic helices can generate curvature 
even on lipid monolayers (Kinuta et al., 2002). An proposed alternative to the bilayer coupling 
mechanism is curvature generation through the restructuring of local lipid arrangement by 
the insertion of the amphipathic helix (McMahon and Gallop, 2005). The insertion of yeast 
Sar1 into the membrane has been directly visualised by cryo-electron tomography and 
subtomogram averaging, showing a 90° kink in the helix into the outer membrane leaflet 
(Hutchings et al., 2018). The generated curvature could result from the asymmetric expansion 
of the outer leaflet or from local lipid rearrangement.  
Sar1 can not only induce, but also sense membrane curvature, as it has been observed that 
purified Sar1 has a greater affinity for artificial membranes of high curvature in vitro (Hanna 
et al., 2016). This is another factor, apart from the GDP-GTP exchange performed by Sec12, 
that limits Sar1 binding to ERES. The high local curvature of the ERES is proposed to be 
maintained by Sar1 and the essential ER-resident factor Sec16, which stabilises the GTP-
bound state of Sar1 that binds the membrane (Supek et al., 2002; Watson et al., 2006). 
Regardless of the greater affinity of Sar1 for highly curved membranes, membrane models of 
varying curvatures, such as synthetic liposomes and giant unilamellar vesicles (GUVs), have 
supported yeast Sar1 binding and yeast COPII budding in in vitro studies (Lee et al., 2004; 
Bacia et al., 2011). 
Sar1 plays multiple roles in COPII vesicle formation, including the sensing and induction of 
membrane curvature, and the recruitment of the rest of the COPII machinery. These two 
functions are seemingly independent, as a truncated form of yeast Sar1 that is deficient in 
inducing membrane curvature (lacking the N-terminal amphipathic helix), but binds to the 
membrane through an engineered tether, can still recruit COPII components (Lee et al., 2004). 
Additionally, Sar1 is involved in the scission of the COPII vesicle from the ER membrane (Bielli 
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et al., 2005; Lee et al., 2005; Hariri et al., 2014). It has been proposed that Sar1 is concentrated 
at vesicle necks, due to its greater affinity for high curvature (Hariri et al., 2014; Hanna et al., 
2016). The high local Sar1 concentration has been implicated in the disruption of local lipid 
packing, enabling vesicle scission (Bielli et al., 2005; Lee et al., 2005). Finally, GTP hydrolysis 
by Sar1 regulates the lifespan of COPII carriers, as Sar1 dissociates from the membrane upon 
GTP hydrolysis. This results in the eventual disassembly of COPII vesicles, as discussed in 
Section I.2.5. (Yoshihisa, Barlowe and Schekman, 1993; Antonny et al., 2001).  
I.2.2. Sec23/24 is recruited by Sar1 
GTP-bound Sar1 recruits cytosolic Sec23/24 heterodimers by directly interacting with Sec23. 
Sec23/24 serves as a molecular adapter and binds cargo, increases membrane curvature, and 
recruits Sec13/31 (Matsuoka et al., 1998; Russell and Stagg, 2010). The Sec23/24 dimer 
possesses a basic concave surface, which has been proposed to induce deformation of the ER 
membrane through electrostatic interactions with acidic membrane phospholipids (Bi, 
Corpina and Goldberg, 2002). Indeed, when the effects of different membrane lipid 
composition on interaction with the Sec23/24-Sar1 complex was tested using synthetic 
liposome models, a proportion of acidic phospholipids proved essential (Matsuoka et al., 
1998). In yeast, the curvature of the basic underside of Sec23/24 is compatible with the range 
of curvatures of COPII vesicles, which suggests that the shape of vesicles can be 
accommodated or moulded by the inner coat proteins (Bi, Corpina and Goldberg, 2002). 
Whether the inner coat is aided by the outer coat in inducing and maintaining COPII vesicle 
curvature is unclear (Barlowe et al., 1994; Bi, Corpina and Goldberg, 2002).  
The inner COPII coat is not only involved in establishing and supporting membrane curvature, 
but also in modulating the GTP cycle of Sar1. The GAP Sec23 specifically stimulates GTP 
hydrolysis by Sar1, and not by other related GTPases (Yoshihisa, Barlowe and Schekman, 
1993). Under the GAP activity of yeast Sec23, yeast Sar1 hydrolyses GTP 10-15 times faster 
than its intrinsic rate (Yoshihisa, Barlowe and Schekman, 1993; Barlowe et al., 1994; Oka and 
Nakano, 1994). As GTP hydrolysis by Sar1 leads to COPII disassembly, the recruitment of 
Sec23/24 is also the first step towards COPII disassembly (Section I.2.5) (Antonny et al., 2001).  
I.2.3. Sec23/24-Sar1 captures cargo 
The Sar1-Sec23/24 ‘pre-budding complex’ recognises and recruits cargo destined for ER 
export. In yeast, Sec24 has been established as the main cargo adapter, although Sar1 and 
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Sec23 are also involved in the capture of some cargo and adapter proteins (Pagano et al., 
1999; Aridor et al., 2001; Miller et al., 2002, 2003; Mancias and Goldberg, 2007; Ma and 
Goldberg, 2016). The cytosolic portion of transmembrane cargo proteins is recognised either 
directly by Sec24 or by cargo adapters, while cargo in the ER lumen interacts with Sec24 
through ER-resident transmembrane adapters (Barlowe, 2003). The cargo selectivity of Sec24 
is determined by cytosolic ER exit signals (Mancias and Goldberg, 2008). In higher eukaryotes, 
analysis of the transport efficiency of the ERGIC-resident reporter protein ERGIC-53 fused to 
different exit signals showed that transport of cargoes with a particular signal is mediated by 
specific, albeit in part redundant, Sec24 paralogues (Wendeler, Paccaud and Hauri, 2007). The 
four different paralogues of Sec24 in mammalian cells have different affinities for specific 
cargo export sequences (Pagano et al., 1999; Mancias and Goldberg, 2008). Different 
transport signal binding sites on Sec24 and one on the Sec23/24 interface have been mapped 
for a range of exit signals (Bonifacino and Glick, 2004). The full range of signals that can be 
differentially identified remains to be explored. Due to the diversity of cargo shapes, sizes, 
and surface charges, nascent carrier formation must be coupled to cargo recognition by the 
Sar1-Sec23/24 complex and further regulated by additional factors (Section I.5.2). However, 
how specific cargo recognition informs and modulates COPII vesicle formation is unclear.  
In yeast, Sec23/24 binding to cargo assists the retainment of the complex on the membrane 
even after GTP hydrolysis by Sar1 (Sato and Nakano, 2005). Retaining the inner coat on 
vesicles after the dissociation of Sar1 can be of functional importance, both for the 
maintenance of vesicle curvature (Section I.2.2) and for fusion with the target membrane 
(Section I.2.5) (Cai et al., 2007). 
I.2.4. Sec13/31 is recruited  
The Sec23/24-Sar1 complex recruits cytosolic Sec13/31 heterotetramers, which do not 
directly interact with the membrane. They assemble to form the outer COPII coat, overlaying 
the inner Sec23/24 coat (Matsuoka et al., 2001). Sec31 interacts with the inner COPII coat 
through a disordered C-terminal proline-rich domain (PRD) (Bi, Mancias and Goldberg, 2007; 
Ma and Goldberg, 2016; Stancheva et al., 2020). Sec13/31 can provide structure to the COPII 
vesicle (Barlowe et al., 1994; Stagg et al., 2006; Noble et al., 2013), but also concentrate 
Sec23/24 heterodimers (Ma and Goldberg, 2016; Hutchings et al., 2018). Furthermore, 
Sec13/31 affects Sar1 GTP hydrolysis by directly modulating Sec23 GAP activity. In yeast, the 
 
   
 
 
  22 
 
 
GTP hydrolysis activity of Sar1 in the presence of Sec23/24 is enhanced ten-fold by Sec13/31. 
Hence, Sec13/31 promotes vesicle uncoating (Yoshihisa, Barlowe and Schekman, 1993; 
Antonny et al., 2001). Therefore, while recruitment of the outer coat is the last step of COPII 
assembly, it also constitutes a major driver of coat disassembly.  
I.2.5. COPII vesicles bud from the ER and fuse with the ERGIC 
The mechanism of COPII vesicle scission from the ER is unclear, and the role of GTP hydrolysis 
in this process has been the subject of much debate. Some studies have suggested that GTP 
hydrolysis is not essential for vesicle formation. In these studies, semi-intact cells or liposome 
budding assays were used, and COPII vesicles were harvested by fast centrifugation (Oka and 
Nakano, 1994; Adolf et al., 2013), which can potentially result in spontaneous vesicle fission, 
especially of membranes that are deformed and constricted by COPII. Contrasting 
observations show that GTP-locked Sar1 and Sar1 complexed with a non-hydrolysable GTP 
analogue are incapable of forming vesicles from semi-permeabilised cells (Schindler and 
Schekman, 2009).  
GTP hydrolysis is central to the dissociation of the COPII coat following scission from the ER 
(Antonny et al., 2001). When Sar1 hydrolyses GTP, as stimulated by the inner and outer COPII 
coats, it undergoes a conformational change and retracts its N-terminal helix from the 
membrane, resulting in its dissociation (Antonny et al. 2001). However, multiple lines of 
evidence suggest that Sec23/24 complexes remain associated with the membrane even in the 
absence of Sar1-GTP. In fact, the potential retainment of the inner COPII coat on vesicles has 
a functional significance, as Sec23 has been shown to mediate vesicle tethering in yeast (Cai 
et al., 2007).  
Sec23 directly interacts with Bet3, a sub-component of the transport protein particle I 
(TRAPPI) tethering complex. TRAPP complexes are required for Golgi fusion of COPII vesicles 
in yeast. Three forms of TRAPP (TRAPPI, II, and III) have been identified, with TRAPPI mostly 
implicated in vesicle tethering through Sec23 (Cai et al., 2007). The interaction between Sec23 
and the TRAPPI tethering complex mediates fusion of COPII vesicles with each other or with 
the acceptor Golgi compartment (Barlowe, 1997; Cai et al., 2007; Lord et al., 2011; Szul and 
Sztul, 2011). The TRAPP-Sec23 interaction suggests a need for outer coat disassembly for 
vesicle fusion with other vesicles or the acceptor membrane. The factor that is proposed to 
promote this disassembly in mammals is Trk-fused gene (TFG), a protein that assembles into 
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oligomers and colocalises with COPII carriers (Hanna et al., 2017). Following vesicle scission 
from the ERES, TFG could outcompete the outer COPII coat through direct interaction with 
the inner coat. This could retain carriers at the ERGIC, restricting their diffusion, and allow for 
vesicle fusion with the ERGIC through exposing the inner coat to TRAPPI machinery (Hanna et 
al., 2017).  
Further evidence that suggests that COPII components could remain associated with vesicles 
after Sar1 disassociation is that Sec23/24 and Sec13/31 can self-assemble in the absence of 
Sar1-GTP, as established with purified human proteins (Stagg et al., 2008). This underlines the 
strength of the interactions between COPII components in the absence of Sar1. Together with 
the observation that cargo stabilises Sec23/24 on the membrane (Section I.2.3), these 
findings suggest that Sar1 GTP hydrolysis and dissociation could precede the complete 
uncoating of the COPII vesicle.  
GTP hydrolysis is essential for the completion of vesicle transport, as fusion with the Golgi 
apparatus is only efficient in vesicles generated with GTP, and not with non-hydrolysable GTP 
analogues (Barlowe, d’Enfert and Schekman, 1993; Oka and Nakano, 1994). Ultimately, after 
coat depolymerisation, COPII components diffuse back to the ER to form new carriers (Forster 
et al., 2006).   
I.3. COPII in the Export of Large Cargo 
Canonical COPII vesicles are 60-80nm in diameter, as observed by thin section electron 
microscopy (EM) of in vitro reconstituted vesicles and in situ using immuno-electron 
tomography (Barlowe et al., 1994; Zeuschner et al., 2006). It has been proposed that their 
size is determined by the outer coat proteins, which self-assemble in vitro into cages of the 
same range of sizes (Antonny et al., 2003; Stagg et al., 2006). The size of canonical vesicles 
would not allow them to accommodate the large molecules that mammalian cells need to 
secrete, such as the elongated precursor of collagen, procollagen (300nm), prechylomicrons 
(75-450nm), laminin (120nm), and mucins (up to 300nm) (Saito et al., 2009; Kesimer and 
Sheehan, 2012; Santos et al., 2016). The export of these large cargoes is important for the 
functioning of mammalian organisms. Procollagens are trimeric helical assemblies, precursors 
of the fibrous collagen proteins, which are the main structural components of the 
extracellular matrix, forming 30% of human body protein dry weight (Bachinger et al., 1982; 
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Junqueira and Carneiro, 2005). While procollagen molecules have traditionally been seen as 
inflexible rods, atomic force microscopy experiments have suggested that procollagen is best 
described as “semiflexible”, with varying degrees of flexibility depending on pH and salt 
concentration (Rezaei, Lyons and Forde, 2018). Prechylomicrons are precursors of 
chylomicrons, lipoproteins found in the blood stream that are essential for efficient fat 
absorption (Hussain, 2000). Laminins are components of the extracellular matrix, regulating 
cell adhesion and differentiation (Petley-Ragan et al., 2016). Mucins are the major constituent 
macromolecules of mucus, crucial for the protection of respiratory epithelia (Voynow and 
Fischer, 2006). COPII components are essential for large cargo export in Caenorhabditis 
elegans, Drosophila melanogaster, zebrafish, mice, and human immortalised cells (Roberts, 
Clucas and Johnstone, 2003; Lang et al., 2006; Townley et al., 2008; Pastor-Pareja and Xu, 
2011; Zhu et al., 2015). Certain mutations in specific paralogues of Sec23, Sec24, and Sar1 
lead to dysfunctions in the secretion of large cargoes such as procollagens and 
prechylomicrons and are therefore implicated in genetic disease (Jones et al., 2003; Boyadjiev 
et al., 2006, 2011; Fromme et al., 2007; Garbes et al., 2015). This is probably due to an inability 
of COPII carriers formed with mutant variants of COPII components to accommodate size 
requirements (Jones et al., 2003; Boyadjiev et al., 2006). The proposed molecular mechanisms 
behind these diseases are discussed in further detail in Sections I.5.1.1 (Sar1) and I.5.1.2 
(Sec23/24). While COPII proteins are essential for the export of large cargo, their precise role 
has been a matter of debate. COPII components have been proposed to form large carriers 
to accommodate large secretory cargo (discussed below), or to play an indirect role in large 
cargo export (see Section I.4) (Fromme and Schekman, 2005).  
If COPII vesicles were to incorporate large cargo, a different, ‘non-canonical’ COPII packaging 
arrangement is necessary. Models for large COPII vesicles have been proposed from 
observations of in vitro reconstituted systems with purified yeast proteins and donor 
membranes. To delay coat dissociation, those studies suppress GTP hydrolysis by using non-
hydrolysable GTP analogues, or the GTP hydrolysis-incompetent yeast Sar1-H77L mutant. 
Incubating membrane donors with purified COPII proteins in the absence of GTP hydrolysis 
results in long coated tubules emanating from the membrane donor (Bacia et al., 2011; 
Zanetti et al., 2013; Daum et al., 2014; Hutchings et al., 2018). COPII in vitro reconstitution 
studies have utilised cryo-electron tomography and subtomogram averaging to gain 
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structural insight into the assembled COPII tubules (Zanetti et al., 2013; Hutchings et al., 
2018). In the absence of GTP hydrolysis by yeast Sar1, yeast Sec23/24-Sar1 heterotrimers 
form a lattice of helical arrays (Zanetti et al., 2013; Hutchings et al., 2018). This establishes 
the role of the inner coat not only as an adaptor/recruiter, but also as a structural determinant 
of membrane morphology. The inner coat lattice determines the orientation of Sar1 with 
respect to the membrane and templates an arrangement of Sar1 molecules that results in a 
parallel insertion of Sar1 helices. The helices are shallowly inserted into the outer leaflet of 
the membrane and then bend at approximately 90°, so that the bent regions align to the long 
axis of the tube. This enables the generation of membrane curvature (Hutchings et al., 2018). 
The assembly of the inner coat lattice is promoted by its interaction with the outer coat 
components. Sec31 contains a proline rich domain (PRD) with multiple triple proline (PPP) 
motifs, and each PPP motif can bind the gelsolin-like domain of Sec23 (Ma and Goldberg, 
2016). In this way, the PRD of Sec31 bridges adjacent Sec23/24 heterodimers, enabling their 
arrangement into an lattice (Hutchings et al., 2018). It has been demonstrated that the outer 
coat can be flexible, as it can coat spherical or tubular membranes and form different 
polyhedral geometries when assembled in vitro depending on the presence or absence of an 
inner coat (Stagg et al., 2006, 2008). The flexible properties of COPII lattices, both individually 
and in respect to each other, demonstrate potential for accommodating a large range of cargo 
(Stagg et al., 2006, 2008; Zanetti et al., 2013).  
The regulation of the size of COPII carriers is linked to the regulation of the GTPase cycle of 
Sar1. As GTP hydrolysis by Sar1 results in coat dissociation, delaying this process can allow for 
the growth of a larger carrier (Antonny et al., 2001). Several lines of evidence suggest that 
this proposed mechanism is relevant not only in in vitro reconstitutions, as discussed above, 
but also in vivo. In humans, the Sar1B paralogue is implicated in the export of large cargo 
(Shoulders, Stephens and Jones, 2004; Levic et al., 2015; Sané et al., 2019). Sar1B has a lower 
affinity for Sec31 when complexed with Sec23 compared to Sar1A, hence GTP hydrolysis by 
Sar1B could be stimulated less strongly by the COPII components (Section I.5.1.1.) (Fromme 
et al., 2007). This paralogue could therefore allow for larger carrier growth by promoting 
slower coat dissociation.  
Furthermore, the large cargo adapter Tango1, which enables procollagen export, is proposed 
to function by delaying GTP hydrolysis by Sar1 (Saito et al., 2009; Malhotra and Erlmann, 
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2011). Tango1 interacts with Sec23 through its PPP motifs, similarly to, and perhaps in 
competition with, Sec31 (Ma and Goldberg, 2016). The GAP activity of Sec23 towards Sar1 
would not be stimulated by Sec31 when Tango1 is bound, therefore coat dissociation would 
be delayed, allowing for the formation of a larger carrier (Saito et al., 2009; Malhotra and 
Erlmann, 2011).  Furthermore, the PPP motifs of Tango1, similarly to those of Sec31, can 
template inner coat assembly. Tango1 is discussed in-depth in Section I.5.2.3. 
I.4. Mammalian COPII Vesicles in vivo 
COPII components are essential for anterograde intracellular transport in mammals (Lang et 
al., 2006; Yang et al., 2013; Wang et al., 2018). However, the existence of free mammalian 
COPII vesicles in vivo has been challenged, unlike that of COPII vesicles in yeast, which is 
universally accepted (Fromme and Schekman, 2005; Watson and Stephens, 2005). 
Mammalian COPII proteins have been suggested to organise the ERES and concentrate cargo, 
rather than coat transport carriers (Mironov et al., 2003; Siddiqi, 2003). Scepticism is largely 
founded on concerns that COPII vesicles cannot accommodate the large cargoes exported 
from mammalian cells (Fromme and Schekman, 2005).  
Staining studies of mammalian fibroblast cells,  which secrete high amounts of collagen, have 
shown retainment of COPII at the ER and no association of COPII with secreted collagen cargo 
carriers (Mironov et al., 2003). These observations were based on immunofluorescence and 
immunogold electron microscopy experiments which utilised a polyclonal antibody against a 
synthetic peptide from human collagen. However, a subsequent analysis using two separate 
monoclonal antibodies against collagen showed collagen colocalization with COPII (Gorur et 
al., 2017). The authors of the latter study suggest that previous use of the polyclonal antibody 
raised against mature collagen might have prevented the detection of the procollagen species 
from the early secretory pathway (Gorur et al., 2017). Correlative video/light electron 
microscopy and tomography have also been used to identify COPII-free procollagen carriers 
dissociated from the ER (Mironov et al., 2003).  Since it remains unclear how long the COPII 
coat is retained on vesicles after fission from the ER in live cells, it is possible that the vesicles 
were already uncoated at the time of observation. 
Evidence in favour of a COPII vesicle model was derived from a combination of immuno-gold 
COPII labelling and electron cryo-electron tomography that showed COPII vesicles in fixed 
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HepG2 cells (Zeuschner et al., 2006). The case was strengthened by a stochastic optical 
reconstruction microscopy study, where large COPII-coated procollagen carriers were 
observed in live cells (Gorur et al., 2017). In situ microscopy studies at a high resolution can 
provide further insight into the precise role of COPII in mammalian anterograde vesicular 
transport. 
I.5. Molecular Mechanisms of COPII 
The COPII secretion system functions through the synergistic action of the COPII components, 
which polymerise to form higher order structures in the context of the intracellular 
environment. Hence, gaining an understanding of the complexities of COPII requires 
investigations on a spectrum of scales: from the structures of individual components and 
subcomplexes, to the structures of COPII assemblies, to the biochemical interactions of COPII 
components in the wider context of the cellular environment. Structures of individual COPII 
subunits and subcomplexes have been elucidated through X-ray crystallography and electron 
microscopy, providing valuable insight into the molecular foundations of COPII component 
function. COPII complexes have been studied by electron microscopy, shedding light on global 
mechanisms of assembly. The interactions of COPII components have been investigated in 
depth in biochemical and genetic studies. Finally, studies of the multiple paralogues of COPII 
components in mammals, some of which have diverged in function, have deepened our 
understanding of the fundamental mechanisms of paralogue-specific pathologies (Boyadjiev 
et al., 2006; Fromme et al., 2007; Kim et al., 2012; Chen et al., 2013; Garbes et al., 2015). The 
insight gained into the COPII system at different scales is described below. 
 
   
 
 





Figure 1.3: Available atomic models of the core COPII components. Crystal structure of human 
Sar1A-GDP (protein database identification code (PDB ID): 2gao). Crystal structure of the 
human Sec23A/24A heterodimer (PDB ID: 2nup). Atomic model of the yeast Sec13/31 
heterotetramer, built from two crystal structures (PDB ID: 2pm6, 2pm9). 
 
I.5.1. Core COPII components 
I.5.1.1. The Sar1 GTPase 
The agent that initiates vesicle formation and scission from the ER membrane is the small 
GTPase Sar1, which belongs to the adenosine diphosphate-ribosylation factor (ARF) family of 
the RAS superfamily (Nakano and Muramatsu, 1989; Yoshihisa, Barlowe and Schekman, 
1993). The ARF family of GTPases are master regulators of the location of the budding process 
and the recruitment of COPII, COPI, and clathrin coats. They recruit the rest of the coat protein 
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complex in their GTP-bound form and are implicated in vesicle scission (Donaldson and 
Honda, 2005). Sar1 is a 22 kilodalton (kDa) magnesium-binding protein, composed of an N-
terminal membrane-binding sequence, followed by a GTPase domain and C-terminal loop 
(Fig. 1.3, Fig.1.4) (Huang et al., 2001).   
 
   
 
 




Figure 1.4: Domain structure and amino acid sequence similarity between paralogues of the 
human COPII secretion system subunits. Percentage similarities have been rounded up to the 
nearest whole number.   
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In vertebrates, there are two paralogues of Sar1, Sar1A and Sar1B, which are both competent 
in initiating COPII vesicle formation and differ in only 20 of 198 amino acids (Fig.1.4, Fig. 1.5) 
(Kuge et al., 1994). However, the paralogues exhibit functional differences, as Sar1B, but not 
Sar1A, mutations are implicated in human disease (Jones et al., 2003). Since Sar1A-Sec23/24 
has a higher affinity for Sec13/31, Sec13/31 might stimulate the GAP activity of Sec23/24 on 
Sar1A more strongly, thereby resulting in faster GTP hydrolysis rates by Sar1A than by Sar1B 
(Fromme et al., 2007). This could result in faster coat disassembly and the formation of 
smaller carriers with Sar1A. Sar1A is therefore proposed to participate in the formation 
canonical 60-90nm-sized COPIII vesicles for the transport of small cargo (Fromme, Orci and 
Schekman, 2008). Sar1B, on the other hand, is thought to specialise in the formation of larger 
carriers, as suggested by its implication in hereditary disorders caused by large cargo 
secretion deficits (Jones et al., 2003). In these disorders, missense mutations of Sar1B result 
alter amino acid residues in its highly conserved GTP-binding pocket, rendering it incapable 
of GTP binding and therefore inactive (Jones et al., 2003). Chylomicron retention disease 
(CMRD) is an early-onset autosomal recessive disease linked to Sar1B mutations, which cause 
a defect in the trafficking of chylomicrons (Jones et al., 2003). The disease manifests in low 
cholesterol levels in the blood and an inability to absorb fats and fat-soluble vitamins D and E 
(Jones et al., 2003). No mutations in Sar1A have been associated with the disease, underlining 
the specific role of Sar1B in the transport of the large chylomicron cargo.  
 
Figure 1.5: Differing residues (red) between Sar1A and Sar1B that lie on the interaction 
interface of Sar1 (yellow) with Sec23 (blue) and with Sec31 (pink). The crystal structure of 
yeast Sar1/Sec23/Sec31 was used (PDB ID: 2qtv). The sequences of yeast Sar1 and human 
Sar1A and Sar1B were aligned with Clustal Omega (Sievers et al., 2011).  
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In vitro, Sar1 is capable of curving membranes in the absence of the other COPII components. 
Addition of Sar1 to artificial membranes yields two kinds of membrane deformation: soft 
tubular formations and rigid tubes, covered by protofilament-like organised lattices (Long et 
al., 2010; Bacia et al., 2011; Hariri et al., 2014). When the structure of the tubes was analysed, 
dimers of Sar1 arranged in a lattice were observed (Hariri et al., 2014). The role of Sar1 
dimerisation in vivo remains uncharacterised. However, its potential importance is elucidated 
by the available hamster Sar1-GDP crystal structure, which also reveals a Sar1-GDP dimer 
(Huang et al., 2001). It is unclear if the dimerisation observed in the crystal structure is 
physiologically relevant, or an artefact resulting from the high protein concentrations used 
for crystallisation. Whether Sar1 membrane deformation in the absence of the rest of the 
COPII machinery is relevant in vivo or is an in vitro artefact also remains to be established.  
I.5.1.2. Sec23/24 
Sec23/24 is a bow-shaped cytosolic dimer that contributes to deformation of the ER 
membrane upon recruitment by Sar1 (Yoshihisa, Barlowe and Schekman, 1993; Bi, Corpina 
and Goldberg, 2002).  
Sec23 is a molecular hub that connects Sar1, Sec24, the outer COPII coat, and additional COPII 
adaptor proteins. Sec23 and Sec24 comprise of β-barrels, helical bunches, zinc-finger 
domains, and gelsolin-like repeats (Fig.  1.3, Fig. 1.4) (Bi, Corpina and Goldberg, 2002).  
The interaction between Sar1 and the Sec23/24 heterodimer has been elucidated in two 
crystallographic studies – of Sar1-Sec23 and of Sar1-Sec23 complexed with a fragment of 
Sec31 - and a recent cryo-electron microscopy study (Bi, Corpina and Goldberg, 2002; Bi, 
Mancias and Goldberg, 2007; Hutchings et al., 2018). Sar1 bound to the non-hydrolysable GTP 
analogue guanylyl imidodiphosphate, known as GMP-PNP, forms an extensive interface with 
Sec23, where an arginine side chain of Sec23 inserts into the Sar1 active site, promoting its 
GTPase activity (Bi, Corpina and Goldberg, 2002). Sec31 also converges with Sec23 at the Sar1 
active site, stimulating the GAP activity of Sec23 (Bi, Mancias and Goldberg, 2007). 
In vertebrates, there are two paralogues of Sec23, Sec23A and Sec23B, and four Sec24 
paralogues, Sec24A-D. The two paralogues of Sec23, Sec23A and Sec23B, are 85% identical in 
sequence (Fig.1.4), but mutations in Sec23A and Sec23B have been implicated in distinct 
disease phenotypes. Mutations in Sec23A can cause cranio-lenticulo-sutural dysplasia (CLSD) 
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(Boyadjiev et al., 2006). CLSD is an autosomal recessive bone formation disorder, resulting 
from defects in procollagen secretion that cause low bone density. Patient-derived fibroblasts 
have decreased collagen secretion efficiency and show an accumulation of biomolecules in 
the ER (Boyadjiev et al., 2011; Kim et al., 2012). Identified disease-causing mutations result in 
single amino acid substitutions in Sec23A, F382L and M702V, proximal to the binding site of 
the active fragment of Sec31 to Sec23. The binding of the active fragment accelerates the GAP 
activity of Sec23 towards Sar1 (Boyadjiev et al., 2006; Fromme et al., 2007; Kim et al., 2012). 
When the efficiency of Sec23A-F382L to interact with the other COPII components was tested 
in vitro, Sec23A-F382L showed to be defective in the recruitment of Sec13/31 
heterotetramers when Sar1B was used. This resulted in lack of vesicle formation. Sar1A could 
bind membranes and form vesicles with Sec23A-F382L, albeit with a lower efficiency, and 
Sec23A-F382L/Sec24 retained its GAP function towards Sar1A (Fromme et al., 2007). These 
observations further underline the specific importance of Sar1B for large cargo export. The 
M702V mutation, on the other hand, did not affect Sec31 binding. Sec23-M702V was shown 
to stimulate the GTP hydrolysis rate of Sar1 further than wild-type Sec23. This resulted in 
premature dissociation of the COPII coat, blocking the export of procollagen (Kim et al., 2012).  
Mutations in Sec23B, and not Sec23A, are implicated in congenital dyserythropoietic anemias 
(Schwarz et al., 2009). This heterogenous group of diseases results from the inefficient 
generation of red blood cells. The different phenotypes caused by Sec23A and Sec23B 
mutations in vivo could be the consequence of different expression patterns, as Sec23A can 
compensate for Sec23B deficiencies (Khoriaty et al., 2017).   
Sec23A is extensively regulated by post-translational modifications, including ubiquitylation 
and phosphorylation (Cohen et al., 2003). Cysteine ubiquitylation sites on Sec23A are 
required for vesicle formation, and these modifications possibly affect the interaction of 
Sec23A with the membrane (Amodio et al., 2017). ULK1, a kinase that is essential for multiple 
cell homeostasis pathways, such as autophagy and endocytosis, phosphorylates Sec23A at 
three different sites (Russell et al., 2013; Gan et al., 2017; Zhou et al., 2017). This disrupts the 
interaction of Sec23A with Sec31 and inhibits ER to Golgi trafficking, probably due to lack of 
outer coat recruitment (Gan et al., 2017).  Furthermore, phosphorylation of Sec23 by a Golgi-
resident kinase in yeast is implicated in vesicle fusion with the Golgi (Lord et al., 2011).  
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The functional differences between the four Sec24 paralogues, Sec24A-D, have been studied 
using knock-out models in mice. Sec24A is non-essential, and its deletion results in normal 
mice with 40% plasma cholesterol reduction (Chen et al., 2013). Sec24B knock-out mice only 
live up to birth and die due to craniorachischisis, a disorder in which both the brain and the 
neural tube remain open (Yang et al., 2013). Sec24C and Sec24D deletions are embryonic 
lethal (Baines et al., 2013; Adams et al., 2014). Osteogenesis imperfecta, a bone formation 
disorder that is associated with defects in collagen secretion, can be caused by Sec24D 
mutations (Garbes et al., 2015). When patient-derived fibroblasts were observed by electron 
microscopy, the deformation of ER domains compared to control fibroblasts from a healthy 
donor was visible (Garbes et al., 2015). ER domains were distended, suggesting that the 
Sec24D mutation could affect general ER export. However, the efficiency of small cargo export 
was not measured. Hence, it remains unclear whether the decrease in procollagen export in 
osteogenesis imperfecta is due to a global decrease in export efficiency, or due to the specific 
importance of Sec24D for large cargo export. Experiments performed on cartilage cells 
isolated from zebrafish embryos provide further insight into the role of Sec24D in the export 
of large cargo (Sarmah et al., 2010). Isolated cartilage cells with Sec24D mutations were 
observed using fluorescent labelling and microscopy. While type II collagen was not secreted 
from these cells, ER export of small membrane-bound cargoes was unaffected. This suggests 
that Sec24D is specifically involved in the export of large cargo (Sarmah et al., 2010). Further 
evidence for this was obtained from studies of the expression patterns of different Sec24 
paralogues in meduka fish using ribonucleic acid (RNA) in situ hybridisation (Ohisa et al., 
2010). Sec24D was preferentially expressed in the notochord and craniofacial cartilage, 
tissues rich in extracellular matrix components, such as collagen, while Sec24A-C isoforms 
were expressed ubiquitously.  
Crystal structures of all four human Sec24 paralogues are available, complementing in vivo 
mutagenesis studies and providing insight into cargo recognition patterns (Mancias and 
Goldberg, 2008). Those exclude the highly variable N-terminal region of Sec24, which is 
disordered in crystal structures (Pagano et al., 1999; Bi, Corpina and Goldberg, 2002).   
In yeast, the regulation of Sec24 by glycosylation and phoshorylation has been demonstrated. 
Sec24 is unable to bind membranes in its deglycosylated and phosphorylated form, which has 
been proposed to regulate COPII trafficking during mitosis (Dudognon et al., 2004).  
 
   
 
 




Sec13/31 are cytosolic heterotetramers, recruited to the pre-budding complex (Sar1-
Sec23/24) through the unstructured C-terminal proline-rich region of Sec31 that interacts 
with Sec23 (Fath et al., 2007). Sec13 and Sec31 form 150nm long elongated tetramers, or 
‘rods’, which are the building blocks of outer coat polymers. Each tetramer consists of two 
Sec13/31 dimers that interact via the central α-solenoid domains of Sec31 (Stagg et al., 2006, 
2008). Each Sec13/31 dimer is formed by a strong interaction between Sec13 and Sec31: the 
two proteins fold together into a b-propeller, in which six blades, or WD40 repeats, are 
formed by the entire Sec13 molecule, and one blade is provided by a linker region of Sec31 
(Fig.  1.6A) (Stagg et al., 2006; Hsia et al., 2007). The N-terminal domain of Sec31 forms 
another β-propeller domain, which constitutes the rod tips and mediates the interaction 
between rods, forming the ‘vertices’ of the assembly (Stagg et al., 2006; Fath et al., 2007; 
Zanetti et al., 2013). At these vertices, the ends of two Sec13/31 rods interact directly with 
each other via their β-propeller domains (referred to as the ‘plus ends’ of the rods), while the 
ends of two other Sec13/31 rods (the ‘minus’ ends) contact them at the side (Fig. 1.6B) (Stagg 
et al., 2008; Noble et al., 2013; Zanetti et al., 2013). The angles between the plus and minus 
ends of the rods at vertices can vary to allow for versatility of coat architecture. It has been 
proposed that the different conformations of Sec31 that enable the formation of ‘plus’ and 
‘minus’ rod ends are dictated by a different extent of interaction between Sec13 and the α-
solenoid domains of Sec31 (Noble et al., 2013).  
 
Figure 1.6: Domain organisation of Sec13/31 heterotetramers and their global arrangement 
in lattice formation. (A) Sec13/31 heterotetramers are formed by the interlocking of the α-
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solenoid domains of Sec31 (atomic model from yeast, PDB ID: 2pm6). The structure of the C-
terminal portion of Sec31, which includes the proline-rich region and the C-terminal domain, 
remains unresolved. (B) The arrangement of Sec13/31 heterotetramers at lattice vertices. 
‘Plus’ ends contact each other directly, while ‘minus’ ends attach at the sides of vertices.  
 
Significant structural insight was gained from studies of purified human Sec13/31, which can 
self-assemble in vitro in the absence of Sec23/24 and membrane (Stagg et al., 2006; Noble et 
al., 2013). The Sec13/31 assemblies, cages of 600Å diameter with cuboctahedral geometry, 
have been characterised by electron microscopy (Stagg et al., 2006; Noble et al., 2013). 
Sec13/31 assemblies have also been examined as assembled in vitro in the presence of 
Sec23/24, where they show a very similar packing arrangement to the Sec23/24-free cage 
(Stagg et al., 2008). While, in this case, the majority of cages assemble as icosidodecahedrons, 
the underlying contacts described above - both the β-propeller vertex and the α-solenoid 
dimerisation interface - remain the same. This suggests that that the intrinsic flexibility of the 
outer cage is sufficient to tolerate different vesicle sizes (Stagg et al., 2008). The extent of the 
flexibility of the outer coat was demonstrated in in vitro reconstitution assays using yeast 
proteins (Zanetti et al., 2013). Purified Sec13/31 proteins were incubated with the inner coat 
components and Sar1 in the presence of membranes and a non-hydrolysable GTP analogue, 
added to retain the COPII components on the membrane. Using cryo-electron tomography, 
long tubules were observed protruding from the membrane donors, where the outer coat 
was organised in a rhomboidal lattice, coating the surface of the tubes. The contacts enabling 
the formation of the outer coat lattice were similar to those described for COPII cages. An 
essential difference in conformation that allowed the formation of tubular lattices was the 
‘hinge’ angle in the middle of Sec13/31 rods. While in spherical cages, this angle was 
approximately 45˚, it was approximately 15˚ in the rhomboid lattice. Variations in this angle 
and the angles at which Sec13/31 rods contact each other at vertices can provide incredible 
versatility to the outer COPII coat, enabling it to create a wide range of shapes to 
accommodate cellular trafficking requirements.  
In yeast, Sec13 is essential for cargo secretion, but this requirement can be circumvented by 
a genetic background that is proposed to have a decreased local cargo load, rendering the 
membrane easier to deform (Čopič et al., 2012). This suggests that the membrane-remodeling 
 
   
 
 
  37 
 
 
capabilities of Sec31 are increased by Sec13 in vivo and supports the insight gained from 
structural studies with human proteins: that Sec13 serves to provide rigidity to outer coat 
rods, here enabling the remodelling of cargo-loaded membranes (Čopič et al., 2012; Noble et 
al., 2013).  
The domains forming the Sec13/31 coat are typical of vesicular carriers. Both clathrin adaptor 
proteins and COPI utilise connected β-propeller-α-solenoid domains. Also called 
‘protocoatomers’, these domains reflect a common evolutionary origin, also shared by the 
ancient nuclear pore complex (Lee and Goldberg, 2010; Dodonova et al., 2015).   
Two paralogues of Sec31, Sec31A and Sec31B, and only one Sec13 are present in mammalian 
cells. Sec31A and Sec31B have 47% sequence similarity. Sec31A is 26% similar to the only 
yeast Sec31 paralogue, Sec31p, while Sec31B is 19% similar to Sec31p (Fig. 1.4). Sec31B relies 
on alternative splicing to produce a range of transcripts, which can be grouped in a short-
form and a long-form family. The long form (Sec31B-F) is similar to Sec31A and Sec31p. 
Sec31B-T, the short form, remains uncharacterised, but is unlikely to participate in the 
formation of the COPII coat because it lacks the C-terminal proline-rich region necessary for 
the Sec23-Sec31 interaction (Stankewich, 2006).   
I.5.2. Additional COPII-interacting partners   
I.5.2.1. Sec12 
In yeast, Sec12, the GEF of Sar1, is essential for COPII vesicle formation in vivo (Barlowe and 
Schekman, 1993). Sec12 was identified as a transmembrane glycoprotein with a prominent 
cytoplasmic domain (Nakano, Brada and Schekman, 1988; D’Enfert et al., 1991). In in vitro 
biochemical studies of both yeast and mammalian systems, the requirement for Sec12 has 
been circumvented by using Sar1 pre-equilibrated with GMP-PNP (Matsuoka et al., 1998; 
Hariri et al., 2014). This suggests that the contribution of Sec12 to COPII vesicle formation in 
vitro is limited to its GEF function. Sec12 is not packaged into nascent COPII vesicles but is 
retained in the ER, ensuring the localisation of Sar1 GTP loading (Weissman, Plutner and 
Balch, 2001). In mammalian cells, Sec12 binds Sec16A, a peripheral membrane protein that 
associates with the ERES (Section I.5.2.2.). Sec16A has been hypothesised to contribute to 
Sec12 concentration in ERES (Montegna et al., 2012). Sec12 could also be recruited to the 
ERES by cTAGE5, an interacting partner of Tango1, as discussed below. 
 
   
 
 




Sec16 is an essential protein that stably localises to the transitional ER in yeast and interacts 
with Sec23, Sec24, and Sec13 (Espenshade et al., 1995; Gimeno, Espenshade and Kaiser, 
1996). Sec16 has been proposed to act as a template for Sec13/31 assembly, as its interaction 
with Sec13 forms an interface reminiscing of that between Sec13 and Sec31 (Whittle and 
Schwartz, 2010). Homologues of Sec16 have been identified in mammalian cells – Sec16A, 
which has a short (Sec16S) and a long (Sec16L) isoform, and Sec16B.  The short and the long 
Sec16A isoforms colocalise and form heteromeric assemblies that are essential to the 
formation of ERES (Bhattacharyya and Glick, 2007).  
I.5.2.3. Tango1/cTAGE5 
Transport-and-Golgi Organisation 1 (Tango1) is a transmembrane cargo adapter family from 
the melanoma inhibitory activity/cutaneous T-cell lymphoma-associated antigen 
(MIA/cTAGE) gene family (Bosserhoff, Moser and Buettner, 2004). Tango1 proteins localize 
at ERES and are conserved throughout metazoans but absent in yeast. They are proposed to 
enable the ER export of cargo that is too large to fit in canonical COPII vesicles, including 
collagen, laminin, and prechylomicrons (Saito et al., 2009; Santos et al., 2016). Tango1 can 
interact with procollagen and is proposed to form elaborate cellular machinery to regulate 
COPII assembly, enabling the formation of large carriers (Saito et al., 2009; Wilson et al., 2011; 
Ma and Goldberg, 2016; Maeda, Katada and Saito, 2017; Raote et al., 2018). 
The MIA/cTAGE family includes two Tango1 isoforms, Tango1 (Tango1-long) and Tango1-
short, and nine other proteins that share similarities with the cytoplasmic portion of Tango1, 
including cTAGE5 and Tango1-like (TALI), which have been implicated in secretion (Feng, Yang 
and Pastor-Pareja, 2021). Tango1-long consists of three cytoplasmic domains, a 
transmembrane domain, and two ER-luminal domains. A cytoplasmic proline-rich domain 
(PRD) interacts with Sec23 and Sec16 (Saito et al., 2009; Ma and Goldberg, 2016). Two 
cytoplasmic coiled-coil domains interact with cTAGE5 and Tango1-short and also recruit 
membranes from the ERGIC (Santos et al., 2015). The ER-luminal domains include a third 
coiled-coil domain and a SH3-domain that interacts with a procollagen chaperone, Hsp47 
(Saito et al., 2009; Wilson et al., 2011; Ma and Goldberg, 2016; Maeda, Katada and Saito, 
2017). Tango1-short has the same structure as Tango1-long, but lacks ER-luminal domains, 
rendering it incapable of interacting with procollagen through Hsp47 (Raote et al., 2018). 
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CTAGE5 has a conserved cytoplasmic domain organization similar to Tango1-long and 
interacts with Sec23, Sec22, and Sec12. Similarly to Tango1-short, it possesses no ER-luminal 
domains (Saito et al., 2011, 2014; Wilson et al., 2011; Raote et al., 2017). TALI is a 
transmembrane protein that has a similar domain organisation to Tango1, consisting of a ER-
lumenal SH3 domain, two cytoplasmic coiled-coil domains, and a cytoplasmic PRD (Santos et 
al., 2016). TALI binds Tango1 and together with Tango1 is required for the export of 
apolipoprotein B (apoB), the main lipoprotein of chylomicrons (Santos et al., 2016). 
Tango1/cTAGE5 bind Sec23, and their interaction has been elucidated by a crystallographic 
study (Ma and Goldberg, 2016). Both Tango1 and cTAGE5 possess PRDs containing multiple 
triple proline (PPP) motifs that can bind Sec23, similarly to Sec31 (see Section I.3).  This 
suggests a competition for inner coat binding between Tango1/cTAGE5 and Sec31 (Lee et al., 
2004; Stagg et al., 2006; Ma and Goldberg, 2016). Since each PPP motif within the Tango1 and 
cTAGE5 PRDs can bind Sec23, the dimer can potentially bind multiple Sec23 molecules of the 
inner COPII coat (Ma and Goldberg, 2016). Binding Sec23 through PPP motifs can template 
the formation of a tubular inner coat lattice, which could allow the carrier to accommodate 
large cargo (Hutchings et al., 2018). A hypothesis for the mechanism of action of Tango1 
suggests that Tango1/cTAGE5 ensures cargo loading and then is gradually displaced by the 
forming Sec13/31 cage, thus remaining secluded to the ER-proximal parts of the forming 
carrier (Ma and Goldberg, 2016). Furthermore, as Sec13/31 increases Sar1 GTPase activity, 
delaying outer coat recruitment could allow for the formation of larger vesicles before vesicle 
fission or coat depolymerisation occurs. The structure of Tango1 has not been elucidated to 
date, and therefore the mechanism of its interaction with the rest of the COPII machinery 
remains unclear. 
While Tango1 can delay GTP hydrolysis by Sar1, cTAGE5 can increase the local concentration 
of GTP-loaded Sar1 by recruiting Sec12. Sec12, which is responsible for the recruitment of 
Sar1 and its loading with GTP, is targeted to the ERES through its interaction with cTAGE5 
(Maeda, Saito and Katada, 2016). While Sec12 is secluded from small COPII vesicles, it is 
enriched in large COPII vesicles (Yuan et al., 2018). Altogether, these observations suggest 
that a high local concentration of GTP-loaded Sar1 facilitates the formation of large carriers 
(Yuan et al., 2018). In vivo, the lack of Sec12 recruitment causes collagen export deficits, which 
are rescued by Sar1 overexpression (Tanabe et al., 2016).  
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A well-studied client cargo of Tango1 is procollagen VII, a trimeric 350kDa assembly and the 
precursor of collagen, the main component of the extracellular matrix (Christiano et al., 
1994). Initially, it was proposed that the export of procollagen is enabled by two interactions: 
the indirect interaction of procollagen with the N-terminal SH3 domain of Tango1, and the 
dimerisation between Tango1 and cTAGE5 through their coiled-coil domains (Saito et al., 
2009, 2011). Surprisingly, a following study suggested that Tango1-short, which lacks the N-
terminal SH3 domain, can substitute for Tango1-long in the export of procollagen (Maeda, 
Saito and Katada, 2016). The mechanism behind this requires further investigation. Large 
rings composed of the two isoforms of Tango1, short and long, and cTAGE5, were observed 
by super-resolution microscopy. The rings surrounded the COPII coat, suggesting the 
formation of a large assembly through lateral interactions at the base of the growing carrier 
(Liu et al., 2017; Raote et al., 2017; Reynolds et al., 2019). 
Tango1 recruits membranes from the ERGIC for collagen export, thereby directly satisfying 
the substantial membrane requirements of large carrier formation (Santos et al., 2015). In 
this way, Tango1 can couple anterograde trafficking of cargo with the retrograde transport of 
the membrane components essential for carrier formation. A model of direct connectivity 
between the ER and ERGIC has been proposed, in which Tango1 tethers the two membrane 
compartments to each other (Raote et al., 2018). However, the connections have not been 
directly observed and would raise questions about the mechanism of preservation of 
compartment identity. As the potential connections are likely to be short-lived and 
dependent on the presence of large cargo in the ER, their direct observation could remain 
challenging.  
Whether Tango1 specifically functions to facilitate the export of large cargo is a matter of 
debate, as the secretion of horseradish peroxidase (HRP), a small soluble protein, is also 
partially impaired by Tango1 depletion (Bard et al., 2006). There are two current hypotheses 
about why some small cargo is retained in the ER when Tango1 is depleted. Firstly, an 
accumulation and potential aggregation of large cargo in the ER can cause ER stress (Sano and 
Reed, 2013). Therefore, large cargo needs to be exported from the ER as soon as it is folded 
and, in the case of procollagen, assembled into its multimeric complex. Perhaps the timely 
formation of large carriers is prioritized, and small cytoplasmic proteins are non-specifically 
exported by these carriers in a mechanism similar to bulk flow. Alternatively, small cargo 
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could be retained in the ER in Tango1-depleted cells, congested by the accumulation of large 
cargo. Furthermore, emerging evidence suggests that Tango1 plays a double role in 
mammalian secretion: as a large cargo adaptor and as an organizing factor of ERES (Saito and 
Maeda, 2019). Both isoforms of Tango1 recruit Sec16, an ERES-organising protein, and a 
depletion of Tango1 results in fewer ERES and delayed secretion (Maeda, Katada and Saito, 
2017). Further investigation is required to understand the role of Tango1 in establishing 
compartment morphology and in the secretion of large cargo versus general secretion.  
CTAGE5 has been proposed to facilitate the export of procollagen in two ways: by building a 
molecular machine together with Tango1 to structure procollagen ER exit sites, and by 
enriching Sec12 in sites of procollagen secretion, enabling the formation of large carriers 
(Tanabe et al., 2016; Raote et al., 2017). CTAGE5 knockdown results in defects in procollagen 
export (Tanabe et al., 2016). Expressing cTAGE5 mutants that are capable of binding Tango1, 
but not Sec12, in a cTAGE5 knockdown background, does not rescue procollagen secretion. 
However, expressing these mutants while overexpressing Sar1 capable of GTP hydrolysis 
rescues procollagen secretion (Tanabe et al., 2016).  
Importantly, Tango1/cTAGE5 deficiencies in mice and humans result in collagen export 
defects and bone formation issues. In mice, these phenotypes are characterised by an 
intracellular accumulation of collagen and an activation of the unfolded protein response 
(Wilson et al., 2011). In humans, a truncation in Tango1 leads to a syndrome characterised by 
severe developmental abnormalities caused by collagen secretion defects. The genetic and 
medical analysis of the affected family suggests that the ratio of truncated to full-length 
Tango1 is key, and at higher ratios symptoms manifest (Lekszas et al., 2020).   
I.5.2.4. Additional factors  
Multiple other factors are specifically implicated in the export of large cargo. Sedlin, a Tango1 
interacting partner and TRAPP component, also affects the export of procollagen from 
mammalian cells. It acts by modulating the GTPase cycle of Sar1, possibly delaying vesicle 
fission (Venditti et al., 2012). 
The CUL3 ubiquitin ligase and its adaptor KLHL12 are involved in the export of large cargo 
(McCaughey and Stephens, 2018). CUL3-KLHL12 are essential for collagen secretion and are 
thought to facilitate the formation of large COPII carriers by monoubiquitinating Sec31. 
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Interestingly, the monoubiquitylation of Sec31 is not on a particular residue, as none of the 
lysine residues in Sec31 are essential for this modification (Jin et al., 2012). Therefore, how 
this modification templates large carrier formation is unclear. The ubiquitination can be 
reversed by the ubiquitin-specific protease USP8 (Kawaguchi et al., 2018). Ubiquitination of 
Sec31 could be physiologically regulated by calcium levels, through the regulation of 
components of the ligase machinery (McGourty et al., 2016).  
I.6.  COPII cargo sorting and autophagy  
Autophagy is an essential process in which cells degrade their cellular contents in response to 
environmental stress. During autophagy, organelles are engulfed in double-membrane 
structures named autophagosomes, which fuse with lysosomes and degrade their content to 
recycle nutrients (Glick, Barth and Macleod, 2010). COPII vesicles play an important role in 
satisfying the high membrane requirements of autophagy (Li, Huang and Wang, 2020). During 
starvation or stress, COPII vesicles contribute to autophagosome formation (Ge, Zhang and 
Schekman, 2014; Shima, Kirisako and Nakatogawa, 2019; Li, Huang and Wang, 2020). COPII 
proteins are not only involved in the general process of autophagy, but also more specifically 
in the autophagy of ER domains (Cui et al., 2019). Misfolded protein domains within the ER 
are marked by ER-phagy receptors and recognised by Sec23/24, either directly or through 
adaptor proteins. Induction of ER-phagy in budding yeast results in an upregulation of ER-
phagy receptors and of their interaction with Sec23 and Sec24 (Cui et al., 2019). Hence, COPII 
components are involved not only in the secretion of correctly folded proteins, but also in the 
degradation of aggregates through ER-phagy. This underlines the important role of Sec23/24 
in cargo control.  
Aberrant expression of the inner coat COPII components has also been linked to ER stress and 
potentially human cancer (Jing, Wang and Liu, 2019). The involvement of COPII in clearing 
aggregated proteins from the ER strongly implicates it in many proteinopathies, including 
neurodegenerative disease.  
I.7. In vitro reconstitutions of COPII 
In vitro reconstitutions of the COPII secretion system utilise artificial membranes and purified 
proteins to provide valuable insight into COPII assembly. Minimal reconstitutions have proved 
indispensable for elucidating COPII mechanisms, even though they are incapable of fully 
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recreating the biochemical make-up of the membrane and the complexity of the protein 
machinery  involved (Daum et al., 2014). 
A variety of lipid membrane models are used to investigate membrane dynamics in a defined 
minimal system with reproducible and known lipid and protein composition. Those include 
lipid bilayers, liposomes, microsomes, small, large, and giant unilamellar vesicles: models of 
different sizes and therefore different membrane curvatures. How the use of specific models 
impacts COPII recruitment and budding has not been thoroughly investigated. However, the 
choice of model is likely of consequence, as Sar1 membrane recruitment and GTPase activity 
increases with membrane curvature (Hanna et al., 2016).  
The chemical properties of membrane lipids can affect not only the recruitment of the COPII 
machinery, but also subsequent membrane remodeling (Daum et al., 2014). The lipid 
requirements for COPII membrane binding in vitro have been investigated using flotation 
experiments (Matsuoka et al., 1998). An optimal lipid composition for yeast COPII binding, 
termed ‘major-minor mix’, was discovered in experiments which estimate protein binding by 
co-fractionation with a floating lipid layer (Matsuoka et al., 1998). The initial mixture that was 
tested in these experiments was similar in composition to microsomal membranes from yeast 
(Zinser and Daum, 1995). While yeast Sar1-GMP-PNP binds liposomes made from a mixture 
of the neutral DOPC-DOPE phospholipids, other COPII components fail to recruit. A negatively 
charged major mix, additionally containing the acidic phospholipids phosphatidylinositol (PI), 
dioleoyl phosphatidylserine (DOPS) and dioleoyl phosphatidic acid (DOPA), binds Sar1 and 
weakly recruits Sec23 and Sec13. A major-minor mix, containing additionally cholesterol, 
phosphatidylethanolamine (PE), and the acidic phospholipids phosphatidylinositol 4-
phosphate (PI(4)P), phosphatidylinositol 4,5-diphosphate (PI(4,5)P2), and cytidine 
diphosphate diacyl glycerol (CDP-DAG), recruits COPII components more strongly than the 
major mix (Matsuoka et al., 1998). Replacing a portion of the PI lipids with PI(4)P in particular 
dramatically increases recruitment of inner and outer coat components (Matsuoka et al., 
1998). Altogether, these results suggest that although initial Sar1-GMP-PNP binding to 
membranes is dependent on neutral phospholipids, acidic phospholipids interact more 
strongly with other COPII components (Matsuoka et al., 1998; Matsuoka and Schekman, 
2000). This could be due to the basic underside of the Sec23/24 heterodimer, which is 
proposed to electrostatically interact with the membrane (Bi, Corpina and Goldberg, 2002). 
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The mammalian ER, as measured from rat liver organelle samples, consists of 57% 
phosphatidylcholine (PC), 21% PE, 9% PI, 4% sphingomyelin (SM), 4% PS, and 5% other lipids 
(Vance, 2015). These include ceramides (Cer), galactosylceramide (GalCer), cholesterol, and 
triacylglycerol (Vance, 2015). This is similar, but not identical, to the optimal lipid composition 
that was established for yeast COPII binding, as discussed above. Investigating COPII binding 
to a lipid mixture identical to that of the native ER can help further unravel the lipid 
determinants of COPII membrane binding.  
Apart from purified COPII proteins and a model membrane, a minimal reconstitution system 
would benefit from the incorporation of cargo. The long-standing need for in vitro budding 
reactions with large cargo was addressed by a cell-free budding assay, in which large spherical 
to ovoid COPII carriers loaded with procollagen I were reconstituted in vitro using purified 
proteins and microsomal membranes extracted from procollagen-expressing cells (Gorur et 
al., 2017). This calls into question studies that suggest that COPII only functions to 
concentrate, but not encapsulate, large cargo (see Section I.4).   
I.8. Project Aims 
The importance of COPII for cargo trafficking in the mammalian cell is well-established, and 
so are the general mechanisms of COPII assembly. Structural information about individual 
core COPII components and subcomplexes is available; however, the human COPII coat 
assembled on membranes has not been observed and characterised. Outstanding questions 
remain: do human COPII components deform membranes for the export of cargo from the 
ER? Are human COPII proteins sufficient for membrane remodelling? What are the minimal 
requirements for reconstituting the functional human COPII secretion system? What is the 
role of GTP hydrolysis in COPII-mediated membrane deformation and scission? How do the 
two poorly characterised Sar1 paralogues, Sar1A and Sar1B, differ in their interaction with 
membranes and with other COPII components? Since Sar1B is specifically implicated in the 
export of large cargo, do the two Sar1 paralogues enable the generation of different 
membrane morphologies?  
The first step to answering the questions above is a minimal reconstitution of the human 
COPII coat assembled on membranes. Human COPII membrane budding has never been 
reconstituted with defined minimal components, suggesting that the essential requirements 
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and conditions for human COPII assembly are still unestablished (Rowe et al., 1996; Aridor et 
al., 1998; Kim et al., 2005; Boyadjiev et al., 2006; Fromme et al., 2007; Gorur et al., 2017).  
In addition to providing a platform for understanding the minimal requirements for budding, 
in vitro reconstitution experiments are a foundation for the structural analysis of the 
assembled COPII coat. The combination of cryo-electron tomography and subtomogram 
averaging has generated valuable insight into the molecular arrangements of the inner and 
outer coats of the yeast COPII secretion system (Zanetti et al., 2013; Hutchings et al., 2018).  
Structural analysis of the human COPII system reconstituted in vitro can elucidate the 
intermolecular interactions between COPII components as assembled on membranes and 
shed light onto global COPII arrangement. Furthermore, substituting with different COPII 
component paralogues in in vitro reconstitution reactions can help explain the role of multiple 
COPII component paralogues in humans in COPII assembly and membrane budding.  
Finally, a minimal reconstitution of the human COPII secretion system can provide a platform 
for the investigation of COPII regulatory components. Understanding how COPII assembly is 
modulated by large cargo adaptors, such as Tango1/cTAGE5, can shed light on the 
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II. Materials and Methods 
 
II.1. Human Sec23A/24C and Sec13/31A expression and purification 
from insect cells  
II.1.1. Bacmid preparation 
 
Deoxyribonucleic acid (DNA) constructs were visualised with SnapGene Viewer.  
DNA constructs of human Sec23A, Sec24C, Sec13, and Sec31A were available in our 
laboratory. The sequences of the proteins of interest were in pFASTbacHTb plasmids, which 
are suitable for bacmid generation for insect cell expression. The pFASTBac-HTb vector 
contains a sequence encoding a 6x Histidine (His) affinity tag, followed by a Tobacco Etch 
Virus (TEV) cleavage site directly upstream from the insertion site for the construct of interest. 
Upon expression, this results in an N-terminal His-TEV polypeptide sequence appended to 
proteins of interest (Fig. 2.1). Sec24C and Sec31A had been directly inserted into the 
pFASBacHTb vector. For Sec23A and Sec13, the 6x His – TEV sequence had been removed.  
 
   
 
 





Figure 2.1: Map of pFASTbacHTb, as generated by SnapGene Viewer. The sequence encoding 
the protein of interest is under the control of a polyhedrin promoter. Upstream of the 
insertion site is a sequence encoding a 6xHis-tag, followed by a sequence encoding a TEV 
protease recognition sequence. This plasmid contains genes encoding ampicillin resistance 
(AmpR) and gentamycin resistance (GmR).  
 
I transformed the relevant pFASTBac constructs into bacmid-containing DH10EMBacY cells, 
resulting in the insertion of the constructs into the bacmid. For each transformation, 1µl of 
plasmid DNA was added to 100µl of electrocompetent DH10EMBacY cells, containing the 
bacmid, pre-thawed on ice for 10 min. The mixture was transferred to a pre-chilled 1mm 
electroporation cuvette, and cells were electroporated by electric pulse (1800V, 200Ω). 900µl 
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of Super Optimal broth with Catabolite repression (SOC) medium (ThermoFisher Scientific) 
was added immediately, and the mixture was transferred to a round-bottom tube and 
incubated in a shaking incubator for 6h at 37 °C at 250 rotations per minute (rpm). 150µl and 
50µl of transformation culture were plated onto selective lysogeny broth (LB) Agar plates 
containing 50µg/ml kanamycin, 10µg/ml tetracyclin, 7µg/ml gentamycin, 20µg/ml 5-bromo-
4-chloro-3-indolyl b-D-galactoside (X-gal), and 120µg/ml isopropyl b-D-1 
thiogalactopyranoside (IPTG) (Sigma-Aldrich). The plates were incubated at 37 °C for two 
days, and white colonies (those contaning pFASTbac-HTb correctly inserted in the bacmid) 
were selected and re-streaked onto selective LB Agar plates, as described above. White 
colonies were selected again and expanded overnight by incubation in 5ml LB Broth with 
kanamycin, tetracyclin, and gentamycin at concentrations as described above, in a shaking 
incubator at 37 °C, 220 rpm.  
Bacmid minipreps were performed following a protocol adapted from the Department of 
Molecular Biology and Biological Physics, University of Virginia. The overnight cultures 
described above were centrifuged for 5 min at 3668 x g using a JS-5.3 swinging rotor (Beckman 
Coulter). The supernatant was removed using a vacuum aspirator, and the pellet was 
resuspended in 300µl of P1 Buffer (Qiagen). 300µl of P2 buffer (Qiagen) was added, and the 
samples were mixed by inversion and incubated for 5 min at room temperature. 300µl of cold 
N3 buffer (Qiagen) were added, and samples were gently mixed by inversion and placed on 
ice for 10 min. During this step, a precipitate of protein/genomic DNA forms. To separate the 
precipitate, samples were centrifuged for 10 min at 21,130 x g using the 5424R benchtop 
centrifuge (Eppendorf). The supernatant was transferred to a tube containing 800µl of room-
temperature isopropanol. The reaction was mixed by inversion and placed at -20°C for 60 
min. The sample was then centrifuged for 15 min at 21,130 x g using a benchtop 
microcentrifuge (5424R, Eppendorf). The supernatant was removed, and 500µl of 70% 
ethanol were added. After mixing by inversion, the tube was centrifuged for 10 min at 21,130 
x g using the 5424R benchtop centrifuge (Eppendorf). The ethanol wash step was repeated. 
All the supernatant was carefully removed, and the pellet was air-dried in sterile conditions. 
The pellet was resuspended in 40µl of sterile water. Bacmid concentration was measured 
using Nanodrop (Thermofisher Scientific), and bacmids were used for transfection of Sf9 
insect cells.  
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II.1.2. Transfection of Sf9 insect cells 
Sf9 insect cells were grown in sterile conditions in Insect Xpress media with L-glutamine 
(Lonza) at 27°C in a shaking incubator at 100 rpm. For all experiments, healthy cells were used 
i.e. uninfected cells that double approximately every 24h, monitored in the 5 days prior to 
use. Prior to transfection, 2ml of healthy Sf9 cells at a density of 0.5x106 counts/ml were 
plated onto Nunclon Delta Surface 6-well plates (Thermofisher) and allowed to adhere for 
30min. Transfection mixture was prepared, containing 200µl medium, 750ng bacmid, and 4µl 
transfectant (FuGENE HD Transfection reagent, Promega). The transfection mixture was 
mixed by gentle flicking and incubated for 30min at room temperature. The mixture was 
added slowly and drop-wise to the plated cells, and the cells were incubated for 5 days. Cells 
were assessed for fluorescence after 5 days, as EMBacY produces yellow fluorescent protein 
(YFP) as a marker; if more than 40% of cells were fluorescent, media was collected, which 
contained the P0 virus. The 2ml of virus-containing media were added to 50ml of Sf9 cells at 
a density of 1x106 counts/ml. After 5 days, cells were centrifuged at 873 x g for 20 min using 
a JS-5.3 swinging rotor (Beckman Coulter), and the supernatant, containing the P1 virus, was 
collected and stored in a light-proof container at 4°C. 
II.1.3. Expression with Bac-to-Bac expression system 
For protein expression, Sf9 cells at 1x106 counts/ml were co-infected with 3ml/L of virus for 
expression of His-tagged proteins (Sec24C, Sec31A) and with 9ml/L for proteins to be co-
purified (Sec23A, Sec13). The virus was directly added to the Sf9 cells, and the cultures were 
returned to the shaking incubator (Lonza) at 27°C for 72h. After this time, cells were checked 
for YFP fluorescence as described above and harvested by centrifugation at 998 x g for 20min 
using a fixed-angle JLA-8.1000 rotor (Beckman Coulter). The supernatant was discarded, and 
the pellet was utilised fresh or stored at -80°C. 
II.1.4. Purification from insect cell culture 
For protein purifications from insect cell culture, I utilised 5ml HisTRAP columns (Sigma-
Aldrich) connected to an ÄKTA Prime system (GE Healthcare Lifesciences), a 1ml MonoQ 
column (Sigma-Aldrich) connected to an ÄKTA Pure system (GE Healthcare Lifesciences), and 
a 2.4ml Superdex 200 column (GE LifeSciences) connected to an ÄKTA Micro system (GE 
Healthcare Lifesciences). Chemical compounds were purchased from Sigma-Aldrich. Where 
His-tag cleavage was performed, TEV protease, purified in-house (by Hutchings, J., Brown, N.), 
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was used at 1:10 protein of interest:TEV protease molar ratio. All purification steps were 
performed at 4°C. Final protein concentrations were measured using a QuickStart Bradford 
assay (BioRad), where absorbance was measured by Nanodrop (Thermofisher Scientific).  
Sec31A forms a stable complex and co-purifies with Sec13. Sec13/31A was purified using a 
three-step purification protocol. Cell pellets were resuspended in 50ml HisTRAP buffer A 
(20mM HEPES pH 7.5, 10% glycerol, 250mM sorbitol, 300mM KOAc, 1mM dithiothreitol (DTT), 
10mM imidazole) plus 2 protease inhibitor tablets (Sigma) per liter of cell culture. Cells were 
lysed using a pre-chilled 50ml glass dounce homogenizer, and cell lysis was assessed by 
staining with Trypan Blue (Thermofisher Scientific). Lysate was filtered using 0.45µm filters 
(Sartorius) and centrifuged at 136,660 x g for 1 hour at 4°C using a Ti45 fixed-angle rotor 
(Beckman Coulter). A 5ml HisTRAP column was equilibrated with HisTRAP buffer A for a 
minimum of 10 column volumes (CVs), and the centrifugation supernatant was loaded at 
1ml/min. The column was washed with 25mM imidazole for 15 CVs, with 60mM imidazole for 
20 CVs, and then eluted using a gradient from 60 to 500mM imidazole for 4 CVs. Samples 
were analysed using sodium dodecyl sulfate – polyacrylamide gel electrophoresis (SDS-PAGE, 
see Section II. 3.).  
Selected samples were pooled, and TEV protease was added. The reaction was transferred to 
a pocket of Spectra/Por dialysis tubing (Spectrum Labs), which was placed in a beaker 
containing 2L of HisTRAP A buffer. The dialysis beaker was stirred with a magnetic stirrer 
overnight at 4°C.  
The overnight cleavage product was recovered from the dialysis pocket and loaded onto a 
5ml HisTRAP column at 1ml/min. This step was performed to allow His-TEV, His-tag 
fragments, and Sec13/31A complexes with an uncleaved His-tag to attach to the HisTRAP 
column and be removed from the solution. The above ÄKTA programme was run again.  
The flow-through was collected and diluted 1:4 in MonoQ buffer A (20mM Tris-HCl pH 7.5, 
1mM MgOAc, 1mM DTT, 10% glycerol) to lower salt concentration. A 1ml MonoQ column was 
pre-washed with MonoQ buffer B (20mM Tris-HCl pH 7.5, 1mM MgOAc, 1mM DTT, 10% 
glycerol, 1M NaCl) and equilibrated in MonoQ buffer A. The diluted post-dialysis HisTRAP 
flow-through was loaded at 1ml/min. The column was washed with 50mM NaCl for 10CVs, 
and a step elution was performed at 500mM NaCl for 10CV. Samples were analysed by SDS-
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PAGE. Selected fractions were pooled, aliquoted, flash-frozen using liquid nitrogen, and 
stored at -80°C. Sec13/31A aliquots were gel-filtrated using Superdex 200 equilibrated in HKM 
buffer (20mM HEPES, 125mM KOAc, 1mM MgOAc, pH 7.5) prior to use in COPII reactions that 
were analysed by electron microscopy.  
Sec24C forms a stable complex and co-purifies with Sec23A. Sec23A/24C was purified using a 
two-step purification protocol, using a HisTRAP column, followed by salt dilution and a 
MonoQ column. The His-tag on Sec24 was retained. Buffers and the general purification 
protocol were the same as described above for Sec13/31A, apart from the specifications 
below. The HisTRAP purification programme consisted of a first column wash with 20mM 
imidazole for 15 CVs, a second column wash with 50mM imidazole for 20 CVs, and a gradient 
elution using from 50 to 500mM imidazole for 4 CVs. Eluted fractions were analysed by SDS-
PAGE, and salt dilution was performed by diluting the identified fractions 1:6 with MonoQ 
buffer A. The monoQ column was washed with 50mM NaCl. Serial step elution from the 
monoQ column was performed using 200mM, 300mM, 400mM, 500mM, 600mM, and 1M 
NaCl. Sec23A/24C eluted at 300mM NaCl. Samples were analysed by SDS-PAGE, aliquoted, 
flash-frozen using liquid nitrogen, and stored at -80°C. 
II.2. Human Sar1A and Sar1B expression and purification from 
Escherichia coli 
II.2.1. Expression in E. coli 
A DNA construct of Sar1A in the pETM-11 vector (Fig. 2.2) was available In our lab, in which 
the Sar1A sequence was preceded by an N-terminal 6xHis-tag sequence, followed by a TEV 
protease cleavage site sequence.  
I generated a construct of Sar1A with a C-terminal 6xHis-tag in the pETM-11 vector. 
Oligonucleotide primers were designed manually, and their melting temperatures were 
assessed with Tm calculator (ThermoFisher Scientific). They were ordered lyophilised from 
Eurofins Genomics. The Sar1A-pETM-11 construct containing an N-terminal 6xHis-TEV was 
used as a template. Oligonucleotides used are shown in Table 2.1, and their annealing 
positions are illustrated in Fig. 2.2 and 2.3. 
 
 
   
 
 




Figure 2.2: Map of pETM-11 containing the Sar1A sequence, as generated by SnapGene 
Viewer. The sequence of interest is inserted downstream of a T7 promoter. Directly 
downstream of the promoter, upstream of the sequence of interest, a sequence encoding a 
6xHis-tag, followed by a TEV protease cleavage site, is positioned. The plasmid contains a gene 
encoding for kanamycin resistance (KanR). The annealing positions of the nucleotides for the 
generation of C-terminally His-tagged Sar1A are shown. 
 
The pETM-11 vector was amplified using primer 1, which anneals to the vector at the 6xHis 
sequence downstream of the Sar1A sequence, and primer 2, which anneals to the vector 
upstream of the 6xHis-TEV site and downstream of the T7 promoter and lac operator. The 
Sar1A sequence was amplified using primer 3, which anneals to the start of the Sar1A 
sequence, with an overhang sequence complementary to primer 1, and primer 4, which 
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anneals to the end of the Sar1A sequence and diverges in sequence at the stop codon, with 
an overhang sequence complementary to primer 2.  
 
Figure 2.3: Annealing positions for the oligonucleotides used for the generation of a construct 
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Primer  Direction Sequence 
1 forward CTCGAGCACCACCACCACC 
2 reverse GGTATATCTCCTTCTTAAAGTTAAATCAAAATTATTTC 
3 forward AGAAGGAGATATACCATGTCTTTCATCTTTGAGTGGATCTACAATG 
4 reverse GTGGTGGTGCTCGAGGTCAATATACTGGGAGAGCCAGCG 
 
Table 2.1: Sequences of the oligonucleotides used for the generation of a Sar1A construct 
with a C-terminal His-tag in the pETM-11 vector.  
 
Sequences were amplified using Q5 High-Fidelity DNA polymerase (NEB). The vector and the 
insert were purified by running the reaction products on an agarose gel and excising the 
appropriate bands. The vector and the insert were ligated using T4 DNA ligase (NEB) at a 1:3 
ratio of vector to insert. Per 20µl of ligation reaction, 2µl of T4 ligase buffer (NEB) and 1µl of 
T4 DNA ligase (NEB) were added. Nuclease-free water (NEB) was added to a total volume of 
20µl. The reaction was mixed and incubated at room temperature for 10 min. Following 
incubation, the enzyme was inactivated using a 10 min 65°C incubation step.  
5ng of ligation product was added into 50µl of DH5a competent cells (Thermo Fisher 
Scientific). The mixture was incubated on ice for 30 min, and cells were permeabilised by heat 
shock at 42°C for 30 sec. 950µl pre-warmed SOC media was immediately added, and the cells 
were transferred to a shaking incubator at 37°C, 250rpm. After 1h, 50ul of the cell mixture 
was spread onto pre-warmed LB Agar plates with 50µg/ml kanamycin. 
DNA constructs of Sar1A and Sar1B in the pGEX-2T vector were available in our lab (Fig. 2.4). 
Their expression produces Sar1 with an N-terminal glutathione S-transferase (GST) affinity 
tag, followed by a thrombin cleavage site. 
All generated plasmids were transformed into BL21 E. coli cells. For each transformation, 
100ng of the plasmid were added to 50µl of pre-thawed cells, and the mixture was flicked 
gently and incubated on ice for 30 min. Cell membranes were made permeable by exposing 
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the mixture to heat shock at 42°C for 10 sec. The mixture was then incubated on ice for 5 min. 
950µl of pre-warmed SOC media were added, and the cells were placed in a shaking incubator 
at 37°C, 250rpm. After 1h, 50ul of the cell mixture was spread onto pre-warmed selective LB 
Agar plates with 50µg/ml ampicillin (for cultures transformed with pGEX-2T) or 50µg/ml 
kanamycin (for pETM-11). Colonies were picked and grown in 5ml of LB Broth with 50µg/ml 
kanamycin (for pETM-11) or 50µg/ml ampicillin (for pGEX-2T) at 37°C overnight, in a shaking 
incubator at 250rpm. The 5ml cultures were diluted in 1L of 2 Yeast Triptone (YT) media (16g 
Bacto Tryptone, 10g Bacto Yeast Extract, 5g NaCl per litre), and the appropriate antibiotic was 
added at 50µg/ml. Cells were grown at 37°C in a shaking incubator at 250rpm to an A600 of 
0.3, transferred to 25 °C, and further grown to an A600 of 0.8. Sar1 expression was induced 
by adding 0.1mM IPTG to the cultures. The protein was expressed for 2h at 25 °C in a shaking 
incubator at 250rpm. Cells were harvested by centrifugation for 20 minutes at 5053 x g using 
a JLA-8.1000 fixed-angle rotor (Beckman Coulter). Cell pellets were frozen at -80°C. 
 
   
 
 




Figure 2.4: Map of pGEX-2T, as generated by SnapGene Viewer. The sequence encoding the 
protein of interest is inserted into the vector under a tac promoter. Downstream of the tac 
promoter, prior to the insertion site of the sequence of interest, is a sequence encoding a 
GST-tag, followed by a sequence encoding a thrombin protease cleavage site. The plasmid 
contains an ampicillin resistance gene (AmpR).  
 
  
II.2.2. Sar1 purification from E. coli 
II.2.2.1. Sar1 N-terminal and C-terminal His-tag purification 
Cells were resuspended in 50ml HisTRAP buffer A (20mM HEPES pH 7.5, 10% glycerol, 250mM 
sorbitol, 300mM KOAc, 1mM DTT, 10mM imidazole) per litre of cell culture. They were 
treated with 20mg lysozyme for 20 minutes, and further lysed using three sonication steps of 
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30s at 40% intensity, with pulses of 1s and pauses of 2s, using a high-intensity ultrasonic 
processor (Vibra cell, Sonics). Lysate was centrifuged at 164,685 x g for 1 hour at 4°C using a 
Ti70 fixed-angle rotor (Beckman Coulter). A 5ml HisTRAP column was equilibrated with 
HisTRAP buffer A for a minimum of 10 CVs, and the centrifugation supernatant was loaded at 
1ml/min. The column was washed with 25mM imidazole for 15 CVs, with 60mM imidazole for 
20 CVs, and then eluted using a gradient from 60 to 500mM imidazole for 4 CVs. Samples 
were analysed on an SDS-PAGE, and selected samples were pooled. For C-terminally His-
tagged Sar1, the pooled sample was concentrated using a 10kDa cut-off concentrator 
(Amicon), aliquoted and frozen at -80°C. For N-terminally His-tagged Sar1, the sample was 
cleaved with TEV protease overnight and dialysed against 2L HisTRAP A buffer, as described 
above in the Sec13/31A purification protocol. The overnight cleavage product was loaded 
onto a 5ml HisTRAP column pre-equilibrated in HisTRAP Buffer A at 1ml/min. This step 
functioned to retain His-TEV, His-tag fragments, and Sar1 with an uncleaved His-tag on the 
HisTRAP column. The above programme was run again. The flow-through, containing Sar1 
with a cleaved N-terminal His-tag, was collected and analysed by SDS-PAGE. It was then 
concentrated using a 10kDa cut-off concentrator (Amicon), aliquoted, flash-frozen using 
liquid nitrogen, and stored at -80°C. 
II.2.2.2. Sar1 N-terminal GST-tag purification 
Pellets were resuspended in 25ml TBST (50 mM Tris, 150 mM NaCl, 0.1% Tween-20, pH 7.4) 
and treated with 20mg lysozyme for 20 minutes. After incubation, Triton X-100 was added to 
a final concentration of 1%, and the sample was mixed by inversion. Cells were lysed using 
three sonication steps of 30s, with pulses of 1s and pauses of 2s, at 40% intensity, using a 
high-intensity Vibra cell sonicator (Sonics). The cell lysate was cleared by centrifugation at 
164,685 x g at 4°C for 1h using a Ti70 fixed-angle rotor (Beckman Coulter) . 4ml of Glutathione 
Sepharose High Performance resin (Merck) were washed and pre-equilibrated with 10 CVs of 
TBST. All centrifugation steps were performed at 500 x g for 5 min at 4°C. The equilibrated 
glutathione beads were incubated with the lysate supernatant for 2h at 4°C on a rolling bench-
top mixer. After incubation, the beads were washed with 40 CV TBST (50mM Tris, 150mM 
NaCl, pH 7.4, 0.1% Tween), 15 CV TBS (50mM Tris, 150mM NaCl, pH 7.4), and 15 CV TCB (50 
mM Tris, 250 mM KoAc, 5 mM CaCl2, pH 8.0). The beads were incubated with 4U thrombin 
protease (GE Healthcare) and 10µM GDP overnight at 4°C on a rolling bench-top mixer. Beads 
 
   
 
 
  58 
 
 
were transferred to an empty gravity flow column. The eluted fraction was collected, and 
another 10 CVs of buffer were added to the beads and collected. Peak fractions were pooled 
and concentrated using a 10kDa cut-off concentrator (Amicon), and aliquots were frozen and 
stored at -80°C.  
II.3. SDS-PAGE analysis 
For SDS-PAGE analysis, unless otherwise specified, 12µl of protein sample were added to 4µl 
of gel-loading dye containing DTT. The mixed sample was incubated at 94°C for 5 minutes and 
centrifuged at maximum speed for 1 minute. Samples were loaded onto NuPAGE 4-12% Bis-
Tris pre-cast gels (Thermofisher Scientific) with 5µl of Precision Plus unstained protein ladder 
(Biorad). Gels were run for 45 min at 210 V in MOPS buffer (Sigma-Aldrich). Gels were stained 
with InstaBlue (Expedeon) for 30min or more and de-stained with deionized water. They were 
imaged on a CanoScan scanner (Canon) or ChemiDoc MP imaging system (BioRad). 
II.4. Preparation of donor membranes 
II.4.1. Preparation of major-minor lipid mixture with cholesterol 
The following lipids were ordered from Avanti Polar Lipids: DOPC, DOPE, DOPA, PI (liver), PI 
(4) P, PI (4,5) P2, CDP-DAG. Texas Red-DHPE was ordered from ThermoFisher Scientific. Lipids 
were dissolved in the appropriate volume of chloroform and mixed to the following molar 
percentages: 51% DOPC, 22% DOPE, 8% DOPS, 5% DOPA, 8% PI (liver), 2.2% PI(4)P, 0.8% PI 
(4,5) P2, 2% CDP-DAG, 1% TX-DHPE to a final lipid concentration of 2mg/ml. Cholesterol was 
added to 20% of the total weight of the mixture. The mixture was aliquoted into 250µl 
aliquots in glass vials with chloroform-resistant caps (ThermoFisher Scientific), dried with 
argon gas, and stored at -20°C.  
II.4.2. Electroformation of giant unilamellar vesicles 
Lipid stock aliquots were dissolved in 50µl of a 2:1 chloroform: methanol solvent, resulting in 
a total lipid concentration of 10mg/ml. 20µl of solution were taken up with a glass syringe 
and applied to the electroconductive sides of two indium tin oxide-coated glass slides, as 
identified by an electroconductivity measurement. The solution was spread to a thin layer on 
the glass slides using a coverslip. Glass slides were dried on a 60°C heat block for 5 min, and 
the electroconductive surfaces were turned towards each other and separated by a silicone 
ring to form a chamber. The chamber was filled with 500ml of 300mM filtered sucrose 
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solution. Metal tape was attached to the electroconductive sides of the chamber, to which 
clipper electrodes were attached. A 10Hz sinusoidal current at 3 Volts effective voltage was 
applied for 6 hours, resulting in the swelling of the lipids and the formation of giant 
unilamellar vesicles. Those were harvested and added to 500ml of 300mM filtered glucose 
solution and left overnight at 4°C. Pellets were formed as the sucrose-filled vesicles sank to 
the bottom of the tube. The sucrose-glucose mixture that overlaid the pellets was removed, 
and the pellet was retained up to 24h at 4°C prior to use. For quality analysis, vesicles were 
pipetted onto glass slides and analysed by fluorescence microscopy. 
II.4.3. Liposome preparation 
Liposomes were prepared from lipid stock aliquots. Aliquots were resuspended in 500µl of 
HKM buffer, pH 6.8. This resulted in a cloudy mixture. Three cycles of the following were 
repeated: vortexing for 1 min, sonication in an ultra-sonic bath (Bransonic 5510, Branson) for 
10 min, flash-freezing, and thawing under a warm water stream. Following this procedure, 
the cloudiness of the lipid mixture was visibly reduced significantly. Liposomes were 
generated using the Avanti Mini Extruder, using a membrane filter with a pore size of 400nm 
(Whatman, GE Healthcare), using 21 passes through the membrane. Liposome preparations 
were assessed by negative-stain EM before use in liposome flotation assays. 
II.5. COPII reconstitution reactions 
To reconstitute mammalian COPII budding reactions in vitro for analysis by electron 
microscopy, giant unilamellar vesicles (GUVs) were combined with Sec23A/24C and 
Sec13/31A purified from insect cells, and Sar1A and Sar1B purified from E. coli (Fig.2.5).  For 
yeast COPII controls, Sar1, Sec23/24, and Sec13/31 were used as purified by Joshua Hutchings 
in-house. Reactions contained 1mM GMP-PNP or a GDP (Sigma-Aldrich), 2.5mM 
ethylenediaminetetraacetic acid (EDTA), and 10% GUVs. The volume was made up to 30µl 
with HKM buffer, pH 6.8. Reactions were incubated at room temperature for one hour and 
prepared for electron microscopy analysis.  
 
   
 
 






Figure 2.5: Reconstitution of COPII budding, adapted from Markova and Zanetti, 2019 
(Markova and Zanetti, 2019). Purified COPII components are incubated with GUVs in the 
presence of GMP-PNP and EDTA. Membrane budding is analysed by electron microscopy 
(EM).  
 
II.6. Electron Microscopy 
II.6.1. Preparation of negative stain electron microscopy grids 
For negative staining, Carbon Support Film Square Grids, 300 mesh, 5-6 nm (Electron 
Microscopy Sciences) were glow-discharged using a PELCO easiGlow Glow Discharge Cleaning 
System (Ted Pella, Inc). 4µl of reaction volume were pipetted onto the grid and incubated for 
1 minute. The grid was picked up using sharp-ended tweezers, inverted, and stained 
sequentially in three drops of filtered 2% uranyl acetate. After 1 min incubation, the stain was 
blotted with filter paper.  
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II.6.2. Preparation of cryo-electron microscopy grids 
Samples for cryo-electron microscopy were prepared using a Vitrobot (ThermoFisher 
Scientific). Lacey carbon film on 300 mesh copper support grids (Agar Scientific) were glow-
discharged using a PELCO easiGlow Glow Discharge Cleaning System (Ted Pella, Inc). 4µl of 
reaction volume were pipetted onto the grid. The reaction was left to absorb into the grid for 
1 min, blotted away, and frozen in liquid ethane. Grids were stored in liquid nitrogen. 
II.6.3. Electron microscopy analysis  
Samples were analysed on T10 or T12 electron microscope (Tecnai), which was aligned using 
common procedures. Data was collected on a Gatan CCD camera, typically with an exposure 
time of 1s per micrograph, using Serial EM software (Mastronarde, 2003). Micrographs were 
analysed using ImageJ software (Schneider, Rasband and Eliceiri, 2012). 
II.7. GTP hydrolysis assays 
To characterise GTPase activity of human Sar1A and Sar1B in the presence or absence of 
Sec23A/24C and Sec13/31A, the commercial GTPase/GAP/GEF-Glo assay was used 
(Promega). The assay was performed using manufacturer’s instructions and adapted as 
applied previously to the study of C. elegans COPII (Hanna et al., 2016). Sar1 was serially 
diluted in GEF buffer. Unless otherwise specified, the total reaction (25µl) consisted of Sar1 
at the respective concentration, 320nM Sec23A/24C or GEF buffer, 320nM Sec13/31A or GEF 
buffer, 1mM DTT, and 5µM GTP in GEF buffer. Reactions were incubated in a solid white 96-
well plate for 30 min, and 25µl of GTPase-Glo reagent were added and incubated for 30 min. 
The GTPase-Glo reagent converts any GTP remaining in the reaction to adenosine 
triphosphate (ATP). 25µl of detection reagent were added, which detects ATP in the reaction 
using a thermostable luciferase, producing a luminescent signal. The reaction was incubated 
with detection reagent for 10 min.  Luminescent signal was measured on a FLUOstar Omega 
plate reader.  
II.8. Liposome flotation assays 
Liposome flotation assays were performed using a protocol adapted from Elizabeth Miller, 
MRC LMB (Fig. 2.6) (Miller et al., 2002). In a 75µl reaction, 50µg liposomes were mixed with 
1µM human Sar1, 320nM Sec23A/24C, and 520nM Sec13/31A, in HKM buffer, pH 6.8, with 
1mM GMP-PNP or GDP and incubated for 1h at 30°C. For yeast COPII controls, we used Sar1, 
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Sec23/24, and Sec13/31 purified by Joshua Hutchings in-house. The reaction was adjusted to 
1M sucrose, using sucrose-HKM, and a final volume of 350µl. The adjusted reaction was 
transferred to a centrifuge tube and overlaid with 350ul 0.75M sucrose-HKM and with 20ul 
HKM buffer. Reactions were centrifuged for 5h at 4°C at 279,982 x g using a Sw55Ti swinging 
rotor (Beckman Coulter). A flotation fraction of 20ul was collected from the top of the tube, 
followed by consecutive 100ul fractions. Liposome recovery was measured by diluting 2µl of 
recovered lipid (i.e., the floating fraction) in 50µl HKM with 0.1% Triton X-100 and comparison 
to a liposome dilution series. Fractions were analysed by SDS-PAGE. 
 
 
Figure 2.6: Liposome flotation assay diagram. COPII reconstitution reactions are incubated 
with liposomes in the presence of GMP-PNP. Reactions are adjusted to 1M sucrose and 
overlayed with 0.75M sucrose, followed by HKM buffer. Following centrifugation, liposomes 
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III. Biochemical Analysis of 
Human COPII Assembly on 
Membranes 
 
In this chapter, I describe the establishment of a system for the reconstitution and 
characterisation of human COPII assemblies in vitro. To this end, I purified the human COPII 
components Sec23A/24C and Sec13/31A from insect cells and human Sar1A and Sar1B from 
E. coli. I assessed and optimised the membrane binding activity of purified COPII components 
and show recruitment of COPII proteins to artificial membranes using liposome flotation 
assays. Furthermore, I characterised the enzymatic activity of the purified proteins, 
confirming that the human Sar1 paralogues I purified have an intrinsic GTPase activity. In in 
vitro GTP hydrolysis assays, the GTPase activity of Sar1 was stimulated by the addition of 
Sec23A/24C and further accelerated by the addition of Sec13/31A. I further compare the 
GTPase activities of the two Sar1 paralogues using purified protein obtained from multiple 
protein purifications. Altogether, I have reconstituted the functional human COPII secretion 
system in vitro.  
III.1. Previous Work  
Studies of the human COPII secretion system have been impeded by the absence of a minimal 
in vitro reconstitution system containing a defined set of purified proteins and membrane 
models. The minimal requirements for human COPII vesicle formation are unestablished, as 
COPII vesicle budding from model membranes has never been achieved with purified human 
proteins in the absence of cytosol.   
Kim et al. established a cell-free reconstitution of mammalian COPII membrane binding (Kim 
et al., 2005). The authors used purified hamster Sar1, mouse 23A/human 24C, and human 
13/31A, and successfully reconstituted COPII binding to synthetic liposomes. They further 
assessed whether COPII components were capable of remodelling cell-derived ER membranes 
and generating transport carriers in in vitro reconstitution reactions. They concluded that 
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purified mammalian COPII proteins were insufficient for membrane remodelling, and that the 
addition of rat liver cytosol was required for membrane budding. They hypothesise that an 
additional factor, providing an essential unknown function, was present in the cytosol. The 
authors conclude that the core mammalian COPII proteins are insufficient for the generation 
of cargo carriers in mammals. Alternatively, they reason that another Sec24 isoform apart 
from Sec24C could be needed for the packaging of the two particular cargo molecules that 
they monitored.  
The membrane binding assay for mammalian COPII components that was used by Kim et al. 
as described above has since been applied to the study of membrane recruitment of mutant 
forms of human Sec23, which are implicated in craniofacial disease (Boyadjiev et al., 2006; 
Fromme et al., 2007). Both studies replicate membrane binding of purified COPII components 
to synthetic liposomes and utilise cytosol for membrane budding reactions. A cell-free 
reconstitution of human COPII carriers has shown packaging of procollagen cargo into carriers 
formed by purified human COPII proteins and cytosol (Gorur et al., 2017). This is a promising 
development for the in vitro study of COPII carriers loaded with large cargo. In this chapter, I 
describe the establishment of a minimal human COPII reconstitution system using defined 
components - purified proteins and model membranes - in the absence of additional cytosolic 
factors. 
III.2. Purification of COPII Proteins 
To reconstitute the human COPII system, I optimised the expression and purification of the 
two human Sar1 paralogues, Sar1A and Sar1B, the inner coat heterodimers Sec23A/24C, and 
the outer coat heterotetramers Sec13/31A. 
III.2.1. Purification of Sec13/31A 
The human Sec13 and Sec31A genes were cloned into separate vectors for insect cell virus 
generation. A hexa-histidine tag, followed by a TEV cleavage site, was introduced on the N-
terminus of Sec31A to allow for metal ion affinity purification. Sec13 contained no tag, and 
Sec31A and Sec13 were simultaneously expressed by co-infecting insect cells for co-
purification. Insect cells were infected with a three-fold excess of Sec13 virus with respect to 
Sec31A to ensure they were purified in stoichiometric amounts for complex formation.  
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The purification of Sec13/31A was designed based on the purification protocol for the yeast 
Sec13/31 complex that was previously established in our laboratory. Briefly, the complex was 
immobilised to a metal affinity resin via the N-terminal His-tag of Sec31 and further purified 
by ion affinity chromatography (Fig. 3.1).  
In the original purification protocol, the His-tag on Sec31 was retained. However, it was since 
established that the N-terminus of yeast Sec31 is essential for outer coat interactions, and 
that a His-tag positioned on the N-terminus disrupts the formation of an outer coat lattice 
(Hutchings et al., 2018). Therefore, I optimised the purification protocol for Sec13/31A to 
include a TEV cleavage step, removing the His-tag after metal affinity chromatography. To 
remove uncleaved Sec31A, the cleaved His-tag, and the His-tagged TEV protease, I introduced 
a reverse affinity chromatography step. To allow for these contaminants to bind to the metal 
ion column during the reverse affinity step, I lowered the high imidazole concentration of the 
sample after metal affinity chromatography using a dialysis step. Lowering the imidazole 
concentration also allows more efficient His-tag cleavage, as high imidazole concentrations 
can result in lower TEV cleavage efficiency (Yeliseev, Zoubak and Gawrisch, 2007). Hence, I 
performed dialysis into a low imidazole buffer simultaneously with TEV cleavage overnight.  
I aimed to produce sufficiently concentrated protein to allow for the screening of a wide range 
of concentrations in in vitro reconstitution experiments. Initially, I eluted Sec13/31A from ion 
exchange columns using gradient elution, and then attempted to concentrate the protein 
using commercial protein concentrators. I observed that the concentration of Sec13/31A did 
not increase proportionally to the volume reduction during concentration, suggesting its 
association with the protein concentrator membrane. Having established that Sec13/31A 
elutes between 50 and 600mM NaCl during gradient elution from the ion exchange column, I 
instead concentrated Sec13/31A by substituting the gradient elution during ion affinity with 
a step-elution with 600mM NaCl. This resulted in the elution of protein at concentrations of 





   
 
 









Figure 3.1: Diagram of the 
purification process of the 
Sec13/31A heterotetrameric 
complex. Sec13/31A was purified 
using metal ion (nickel) affinity 
purification, followed by a reverse 
metal affinity step and ion 
exchange purification using a 
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Sec13/31A formed a stable complex, as shown by the presence of Sec13 throughout the 
purification. The formation of a Sec13/31A complex suggests that both proteins are correctly 
folded. While in SDS-PAGE analysis (Fig. 3.3B), the band corresponding to the molecular 
weight (MW) of Sec31A is sharp, the band corresponding to the MW of Sec13 is smeared, 
suggesting the presence of multiple species. Human Sec13 is proposed to be phosphorylated 
at two positions, S184 and S309 (Olsen et al., 2010; Zhou et al., 2013). The presence of 
multiple phosphorylation states of Sec13 in the sample could explain the appearance of the 
band.  
 
   
 
 





Figure 3.2: Metal ion affinity purification of Sec13/31A using a hexa-histidine tag on Sec31A. 
A representative purification is shown. Sec13/31A bind and co-purify. (A) Sec13/31A elutes 
as a monodisperse peak from a HisTRAP column at an average concentration of 200mM 
imidazole. (B) SDS-PAGE analysis of HisTRAP fractions.  
 
   
 
 





Figure 3.3: Anion exchange purification of Sec13/31A. A representative purification is shown. 
(A) Sec13/31A elutes as a monodisperse peak from a MonoQ column at 600mM NaCl. (B) SDS-
PAGE analysis of MonoQ fractions.         
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Throughout optimisation, all Sec13/31A purifications yielded protein samples that, when 
analysed by SDS-PAGE, showed multiple faint bands under the band corresponding to the 
molecular weight of Sec31. This suggests that Sec31 is undergoing degradation during the 
purification process.  
To assess whether the purified Sec13/31A is functional despite the degradation, I analysed its 
ability to self-assemble. Self-assemblies of human Sec13/31, or cages, have been observed in 
previous reports (Stagg et al., 2006; Noble et al., 2013). When I analysed purified Sec13/31A 
by negative stain EM, I observed Sec13/31A cages (Fig. 3.4). This suggests that the purified 
outer coat components can form functional assemblies.  
 
Figure 3.4: Cages of Sec13/31A observed by negative stain EM. Sec13/31A was added to the 
grids at a concentration of 30µg/ml in HKM buffer.  
 
The buffer conditions under which I observe cage assembly are comparable to those of 
previous studies. Studies of human COPII cages used protein dialysis into high salt buffer to 
allow for cage assembly (Stagg et al., 2006; Noble et al., 2013). For cryo-EM analysis, samples 
were dialysed into a low-salt buffer. Lowering the salt concentration before cryo-EM sample 
preparation is beneficial, as higher salt concentrations decrease contrast during electron 
microscopy imaging (Drulyte et al., 2018). In the final Sec13/31A purification step, I used a 
high salt buffer (20mM Tris-HCl pH 7.5, 600mM NaCl, 1mM MgOAc, 1mM DTT, 10% glycerol) 
 
   
 
 
  71 
 
 
step-elution from a anion exchange column. For imaging, I diluted the sample 16-fold into low 
salt HKM buffer (20mM HEPES pH 6.8, 160mM KOAc, 1mM MgCl2).  
The cages that I observed using negative stain EM were of a range of diameters between 680Å 
and 920Å (Fig. 3.5). This range of diameters is similar to the one previously observed for yeast 
and human Sec13/31 cages (Antonny et al., 2003; Stagg et al., 2006, 2008; Bhattacharya, 
O’Donnell and Stagg, 2012).  
Previous studies have suggested that sample preparation methods are important for the 
homogeneity of Sec13/31 cages and must therefore be considered for high-resolution 
structure determination (Noble et al., 2013). Analysis of Sec13/31A cryo-EM grids using cryo-
electron tomography suggested that significant amounts of unassembled Sec13/31A were 
present in the sample, which were contributing to sample heterogeneity and were an 
impediment to imaging. To separate Sec13/31A that was incorporated into cages from 
unassembled proteins, the authors centrifuged the sample through a sucrose-glutaraldehyde 
gradient. While I observe little background signal in negative stain EM, this procedure could 
be beneficial for the preparation of grids of Sec13/31 cages.  
 
 
Figure 3.5: Size distribution of purified human Sec13/31A cages assembled in vitro.  
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III.2.2. Purification of Sec23A/24C 
Human Sec23A and Sec24C genes were cloned into separate vectors for insect cell virus 
generation. A N-terminal hexa-histidine tag was introduced on Sec24C to allow for metal ion 
affinity chromatography. The proteins were co-expressed in Sf9 cells. As Sec23A was purified 
using co-purification with the tagged Sec24C, a three-fold excess of Sec23A virus was added 
to insect cells, compared to the Sec24C virus. The purification of Sec23A/24C is shown in 
Figures 3.6, 3.7, and 3.8.  
Initially, the purification of human Sec23A/24C was based on the human Sec13/31A 
purification protocol, which was optimised as discussed above. However, during the 
overnight cleavage and dialysis step, Sec23A/24C non-specifically associated with the dialysis 
tubing, which I determined by measuring the concentration of the sample before and after 
dialysis. The dialysis step therefore resulted in purifications with consistently low protein yield 
and concentration. To increase protein yield, the overnight dialysis and cleavage step was 
eliminated, and the His-tag on the Sec24C was retained. The N-terminus of Sec24C is highly 
variable and has not been shown to be involved in the interactions between core COPII 
components (Pagano et al., 1999; Bi, Corpina and Goldberg, 2002). In yeast reconstitutions, 
the inner coat can assemble with or without the His-tag on Sec24C (Hutchings, J., Pyle, E., 
personal communication). Hence, I hypothesised that the retainment of the His-tag would 
not disrupt COPII assembly in reconstitution reactions. (Indeed, the purified Sec23A/24C was 
capable of forming an inner coat, see COPII Budding Reactions by Electron Microscopy, Section 
IV.3.2). The optimisation allowed for the purification of Sec23A/24C to 0.3mg/ml, which is 
sufficient for its use in COPII budding reactions.  Attempts to concentrate Sec23A/24C to a 
concentration above 0.35mg/ml resulted in its aggregation (data not shown), which is 
consistent with previous observations of the aggregation-prone nature of the yeast inner coat 






   
 
 










Figure 3.6: Diagram of the purification process 
of the Sec23A/24C heterodimeric complex. 
Sec23A/24C was purified using metal ion 
(nickel) affinity purification, followed by ion 
exchange purification using a MonoQ anion 
exchange column.  
 
 
   
 
 




Figure 3.7: Metal ion affinity purification of Sec23A/24C using a hexa-histidine tag on Sec24C. 
A representative purification is shown. Sec23A/24C bind and co-purify. (A) Sec23A/24C elutes 
from a HisTRAP column at an average concentration of 200mM imidazole. (B) SDS-PAGE 
analysis of HisTRAP fractions. 
 
   
 
 





Figure 3.8: Anion exchange purification of Sec23A/24C. A representative purification is 
shown. (A) Sec23A/24C elutes from a MonoQ column as a monodisperse peak at 500mM 
NaCl. (B) SDS-PAGE analysis of MonoQ fractions.       
     
III.2.3. Purification of Sar1 
Initially, Sar1A was cloned into an E. coli expression vector with a N-terminal hexa-histidine 
tag, followed by a TEV protease cleavage site. The protein was purified using a metal ion 
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affinity purification protocol. The N-terminus of Sar1 is essential for membrane binding 
(Goldberg, 1998; Huang et al., 2001; Bi, Corpina and Goldberg, 2002; Bielli et al., 2005; 
Hutchings et al., 2018). Therefore, to expose the N-terminus, the N-terminal His-tag was 
cleaved overnight using TEV protease. The cleavage step was performed simultaneously with 
dialysis into a low-imidazole buffer to allow for reverse metal ion affinity chromatography. In 
the reverse affinity step, the cleaved His-tag, the uncleaved protein fraction, and the His-
tagged TEV protease were removed. The purification method is illustrated in Figure 3.9B, and 
the final purified protein is shown in Figure 3.9C, lane 2.  
 
 
Figure 3.9: Metal ion affinity purification of Sar1A with a hexa-histidine tag. (A) Schematic of 
the purification of Sar1 with a C-terminal His-tag, which was retained. (B) Schematic of the 
purification of Sar1 with an N-terminal His-tag, cleaved with TEV protease after the nickel 
affinity binding step. (C) SDS-PAGE analysis of the final purified proteins: 1. Sar1A with a 
retained C-terminal tag, purified as shown in (A). 2. Sar1A with a cleaved N-terminal tag, 
purified as shown in (B).  
 
   
 
 




While Sar1 appears pure and is of the expected molecular weight, liposome flotation assays 
showed that the protein was unable to bind membranes (see Section III.3.). To assess whether 
degradation or loss of the N-terminal helix of Sar1 could be the reason for lack of membrane 
binding, the purified Sar1A protein was commercially analysed by mass spectrometry and 
proved intact. I hypothesised that the initial presence of the N-terminal tag or the process of 
its cleavage could have disrupted the native conformation of Sar1. To assess whether this 
could be the reason behind the lack of membrane binding, I generated a construct encoding 
for Sar1 with a C-terminal hexa-histidine tag, instead of the N-terminal tag. The C-terminal 
His-tag was retained. The purification process is illustrated in Figure 3.9A, and the final 
purified protein is shown in Figure 3.9C, gel lane 1. This protein also proved unable to bind 
membranes when assessed using liposome flotation assays.  
Finally, I turned to purifying Sar1 using a glutathione affinity purification protocol that has 
previously been used for hamster Sar1 purification in the literature and shown to yield 
functional protein (Kim et al., 2005). I generated a DNA construct encoding for Sar1A with an 
N-terminal GST-tag, followed by a thrombin cleavage site, expressed the protein and purified 
it using glutathione affinity purification. The tag was cleaved overnight after the affinity step 
to expose the N-terminus of Sar1 and to allow for Sar1 membrane binding (Goldberg, 1998; 
Huang et al., 2001; Bi, Corpina and Goldberg, 2002; Bielli et al., 2005; Rao et al., 2006; 
Hutchings et al., 2018). GDP was added to a 10µM concentration during the cleavage step to 
stabilise the inactive (GDP-bound) conformation of Sar1 after the cleavage of the bulky N-
terminal GST-tag. Nucleotide addition can enhance protein stability (Waldron and Murphy, 
2003) and ensure that the protein population is in a single conformational state. Using this 
purification protocol (Fig. 3.10A), I observed a prominent band corresponding to the 
molecular weight of Sar1A, 22kDa (Fig. 3.10B).  
 
   
 
 




Figure 3.10: Glutathione affinity purification of Sar1A and Sar1B. (A) Purification procedure 
schematic. The GST-tag on Sar1 is used in the initial affinity step and is subsequently cleaved 
with thrombin protease in the presence of GDP. (B) SDS-PAGE analysis of selected fractions 
from the purification of Sar1A with a cleaved N-terminal GST-tag (Mw 22kDa). (C) SDS-PAGE 
analysis of fractions throughout the purification of Sar1B with a cleaved N-terminal GST-tag 
(Mw 22kDa). 
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When tested in liposome flotation assays, the protein obtained with the latter method 
showed to be functional and bound membranes (see Section III.3.).   
The amino acid sequences of the cleaved N-terminally His-tagged Sar1A and the cleaved N-
terminally GST-tagged Sar1A are the same, and it is difficult to reason why the latter is active 
in membrane binding while the former is not. The differences in membrane binding between 
the two could be due to differences in conformation. This could be caused by the different 
construct design and purification procedures and is addressed in further detail in the 
Discussion. 
Building up on the optimisation performed for Sar1A, I cloned Sar1B with an N-terminal GST-
tag, followed by a thrombin cleavage site, and purified it using glutathione affinity purification 
(Fig. 3.10B). The purification produced protein that corresponded to the molecular weight of 
Sar1B, 22kDa (Fig. 3.10C) The ability of this protein to bind membranes was confirmed using 
liposome flotation assays (see Section III.3.).  
III.3. COPII Membrane Binding 
Initially, I attempted to characterise the binding of purified human COPII proteins to donor 
membranes using negative stain EM analysis of in vitro reconstitution experiments. I observed 
that the COPII components I initially purified were not efficient in deforming membranes and 
that they did not form a stable coat (see COPII Budding Reactions by Electron Microscopy, 
Section IV.2). I hypothesised that this was due to poor Sar1 binding to membranes, which 
could result in insufficient COPII component recruitment for coat formation. Observing 
assemblies by EM does not allow for quantitative assessment of membrane binding. 
Therefore, to assess and improve membrane binding of purified COPII components, I used a 
membrane recruitment assay.  
I set out to assess the binding of COPII components to liposomes in the presence of GMP-PNP 
or GDP. Upon GDP to GTP exchange, Sar1 is proposed to undergo a conformational change 
and project an N-terminal helix which inserts into membranes (Goldberg, 1998; Huang et al., 
2001; Bi, Corpina and Goldberg, 2002; Bielli et al., 2005; Rao et al., 2006; Hutchings et al., 
2018). Upon GTP hydrolysis, Sar1 undergoes an opposing conformational change, retracting 
its N-terminal helix (Antonny et al., 2001). Hence, I expected that Sar1 would be recruited to 
liposomes in the presence of a GTP analogue, and less so in the presence of GDP. 
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I used yeast COPII components previously purified in our laboratory as a positive control 
during my initial optimisation of liposome flotation reactions. The binding of yeast COPII 
proteins to liposomes in liposome flotation assays has been well-established in the literature 
(Matsuoka et al., 1998, 2001; Matsuoka and Schekman, 2000; Bigay and Antonny, 2006). The 
binding of this particular set of purified yeast proteins has been shown previously by our 
collaborators (Hutchings et al., 2018). I observed that using this assay, I can detect membrane 
recruitment of yeast COPII components in the presence of GMP-PNP (Fig. 3.11, see Methods, 
Fig. 2.6). To optimise the amount of liposomes to use in liposome flotation assays, I tested 
the recovery of yeast COPII proteins in the floating fraction when using 10 µg and 50 µg of 
liposomes. Faint bands corresponding to yeast COPII proteins can be observed in the floating 
fraction with 10µg of liposomes per reaction (Fig. 3.11A, Gel lane 2).  More intense bands 
corresponding to COPII can be observed in the floating fraction when the amount of 
liposomes used in the reaction is increased to 50µg (Fig. 3.11B, Gel lane 1). As increasing the 
amount of liposomes from 10µg to 50µg increases the recovery of yeast COPII proteins, 50µg 
of liposomes were used in further liposome flotation reactions. 
 
Figure 3.11: Yeast COPII recruitment to membranes in liposome flotation assays as observed 
by SDS-PAGE in two separately conducted experiments. (A) Gel lanes 2-9: most to least 
floating fractions following centrifugation. 10µg of liposomes used per 75µl reconstitution 
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reaction. (B) Gel lanes 1-8: most to least floating fractions following centrifugation. 50µg of 
liposomes used.  
When I performed liposome flotation assays using a 1µM concentration of Sar1A purified by 
nickel affinity purification, I could not detect membrane recruitment in the presence of GMP-
PNP (Fig. 3.12A, Gel lane 1), suggesting that Sar1A purified using by nickel affinity purification 
is inefficient in membrane binding. The same concentration of Sar1 was capable of membrane 
remodelling, albeit inefficient, as observed by EM (see COPII Budding Reactions by Electron 
Microscopy, Section IV.2.). This could be explained by the higher sensitivity of EM analysis.  
Aiming to produce Sar1A that efficiently binds membranes, I generated N-terminally GST-
tagged Sar1A and purified it by glutathione affinity purification (Section III.2.3.). When I added 
the same concentration (1µM) of Sar1A purified by glutathione affinity to liposomes as used 
above for Sar1A purified by nickel affinity, I detected the recruitment of the protein to 
liposomes (Fig. 3.12B, Gel lane 1). Sar1B purified by glutathione affinity purification was also 
capable of binding membranes (Fig. 3.12D, Gel lane 1). This suggests that the choice of Sar1 
construct and the protein purification protocol used can affect membrane binding. To further 
optimise the recruitment of Sar1 to membranes, I introduced an incubation step with GMP-
PNP to allow for more complete nucleotide exchange.  
Both paralogues were recruited to membranes with GMP-PNP (Fig. 3.12). However, 
membrane binding for both paralogues was also observed in the presence of GDP (Fig. 3.12C 
and E). The finding that human Sar1 is capable of binding membranes when bound to GDP 
agree with previous observations by Kim et al. with purified hamster Sar1A, which has a 99% 
sequence identity to human Sar1B (Kim et al., 2005). I further observed that the nucleotide 
state made a greater difference to Sar1B than to Sar1A membrane binding.   
 
 
   
 
 




Figure 3.12: Sar1A and Sar1B purified by glutathione affinity purification bind liposomes. The 
nucleotide state makes a greater difference for Sar1B binding than for Sar1A binding. (A-E) 
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Gel lanes 1-7: most to least floating fractions following centrifugation. Gel lane 8: protein 
input. (A) 1µM Sar1A purified by nickel affinity purification (B, C) 1µM Sar1A purified by 
glutathione affinity purification (D,E) 1µM Sar1B purified by glutathione affinity purification 
(B,D) 1µM GMP-PNP (C, E) 1µM GDP. 
When Sar1A was incubated with GMP-PNP, an additional 17kDa band was visible in the SDS-
PAGE input fraction (Fig. 3.12B, Gel lane 8). This band likely represented a Sar1 degradation 
product. It did not appear when Sar1A was incubated with GDP, suggesting that it only 
resulted from the GTP-analogue-bound Sar1A state (Fig. 3.12C, Gel lane 8). This band was not 
observed in the floating fraction incubated with GMP-PNP (Fig. 3.12B, Gel lane 1), suggesting 
that it is not capable of binding membranes. Furthermore, no additional band was observed 
for GMP-PNP-bound Sar1B (Fig. 3.12D).  
Having established the optimal purification protocol for Sar1 and optimised the conditions for 
Sar1 membrane recruitment, I set to optimise the recruitment of the inner and outer COPII 
components to the membrane. First, I tested the recruitment of inner coat components to 
liposomes in the presence of Sar1B purified by glutathione affinity purification (Fig. 3.13A and 
B). In the presence of the non-hydrolysable GTP analogue, Sar1B recruited the inner coat 
components to liposomes (Fig. 3.13A, Gel lane 1). In the presence of GDP, while Sar1B was 
partially bound to membranes, it did not recruit Sec23A/24C (Fig. 3.13B, Gel lane 1). This 
suggests that GMP-PNP-bound Sar1B is more efficient at inner coat binding than GDP-bound 
Sar1B. This observation is in agreement with the results of previous experiments on human 
COPII membrane binding, where the recruitment of Sar1B and Sec23/24 to liposomes was 
assessed using liposome flotation assays (Boyadjiev et al., 2006). In these experiments, Sar1B 
was added to liposomes in the presence of inner coat components and either GDP or the non-
hydrolysable GTP analogue GTPjS. Sar1B was recruited to liposomes with either nucleotide. 
However, it was capable of recruiting the inner coat only in the presence of GTPjS. This 
suggests that the affinity of Sar1B for Sec23/24 is dependent on its nucleotide state. 
After assessing that the inner coat was recruited to membranes by Sar1B in the presence of 
the GTP analogue, I performed liposome flotation experiments using the full set of COPII 
proteins: Sar1B, the inner coat components Sec23A/24C, and the outer coat components 
Sec13/31A. Sar1B recruited the full set of COPII components to liposomes in the presence of 
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the GTP analogue (Fig. 3.13C). In the presence of GDP, no COPII components could be 
observed in the floating fraction (Fig. 3.13D). This contrasts previous observations by Kim et 
al., in which the full set of COPII proteins was recruited to liposomes both in the presence of 
GMP-PNP and of GDP (Kim et al., 2005). Altogether, purification of Sar1B through N-terminal 
GST-glutathione affinity produced Sar1 that binds membranes and recruits inner and outer 
coat components. 
 
Figure 3.13: Sar1B binding to liposomes in the presence of GMP-PNP recruits the inner and 
outer COPII components. The COPII coat is not recruited to liposomes in the presence of GDP. 
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(A,B) Gel lanes 1-6: most to least floating fractions following centrifugation. Gel lane 7: protein 
input. Reactions contained 1µM Sar1B, 320nM Sec23A/24C, and 320nM Sec13/31A. (C,D) Gel 
lanes 1-7: most to least floating fractions following centrifugation. Gel lane 8: protein input. 
Reactions contained 1µM Sar1B, 320nM Sec23A/24C. (A, C) 1µM GMP-PNP (B,D) 1µM GDP. 
III.4. GTP hydrolysis activity of Sar1A and Sar1B and COPII  
To establish whether the proteins I purified were fully functional, I investigated whether the 
COPII system had retained its enzymatic activity. Sar1 hydrolyses GTP, which is essential to 
its function in the cell. The mechanism of GTP hydrolysis by COPII is described in detail in the 
Introduction. Briefly, Sar1 exchanges GDP to GTP as stimulated by its cognate GEF, Sec12 
(Nakano, Brada and Schekman, 1988). GTP hydrolysis by Sar1 is stimulated by its GAP, Sec23 
(Yoshihisa, Barlowe and Schekman, 1993; Barlowe et al., 1994; Miller et al., 2003). Sec31 
further stimulates the GAP activity of Sec23 (Yoshihisa, Barlowe and Schekman, 1993; 
Antonny et al., 2001).   
I performed in vitro experiments to investigate whether the Sar1 I purified is a functional 
GTPase and whether it has retained its functionally relevant interactions with the inner and 
outer COPII coats. In addition to assessing functionality, the setup of GTP hydrolysis assays 
is suitable for the investigation of differences in GTP hydrolysis between the two Sar1 
paralogues. This can provide insight into their fundamental functional divergence and the 
implication of Sar1B in paralogue-specific pathologies (see Introduction, Section I.5.1.). The 
GTP hydrolysis activity of the two Sar1 paralogues has previously been studied using 
tryptophan fluorescence assays (Fromme et al., 2007; Kim et al., 2012; Melville, Studer and 
Schekman, 2020). In these assays, the nucleotide state of Sar1 is assessed using its 
tryptophan fluorescence. Due to the conformational differences between GTP- and GDP-
bound Sar1, the fluorescence signal of Sar1 is higher in its GTP-bound state than in its GDP-
bound state (Antonny et al., 2001; Futai et al., 2004). These studies find no difference 
between the GTP hydrolysis rate of Sar1A and Sar1B in the presence the other COPII 
components. Fromme et al. find that the GTP hydrolysis activity of Sar1A and Sar1B is equally 
stimulated by the addition of inner coat components and further enhanced by the addition 
of the outer coat components (Fromme et al., 2007). In this study, the intrinsic GTP 
hydrolysis activity of Sar1 was not assessed. A recent investigation of the differences 
between the two Sar1 paralogues concluded that the two Sar1 paralogues have similar 
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intrinsic GTP hydrolysis rates (Melville, Studer and Schekman, 2020). The authors, however, 
find that Sar1A exchanges GDP for GTP faster than Sar1B.  
Initially, I assessed the GTPase activity of nickel affinity-purified Sar1A on its own and in the 
presence of the purified inner coat components. I used a commercial GTPase activity assay 
which was previously used for the study of C. elegans COPII (Hanna et al., 2016). I added 
Sar1A at a range of concentrations from 0.2 to 6.4µM, since 6.4µM was the highest Sar1A 
concentration obtainable in the final reaction, determined by the protein concentration I 
obtained from purification. The concentration of the inner coat proteins I added, 255nM, 
was the same as used in the above study of C. elegans COPII (Hanna et al., 2016). In this 
initial experiment, I did not include the outer coat components, as they were not included 
in the original C. elegans study. According to the manufacturer’s instructions, the optimal 
incubation time in these reactions is highly sample-specific, and in this initial experiment I 
assessed the extent of GTP hydrolysis in the reaction after 30 minutes. I measured the 
absolute luminescence counts from each reaction, corresponding to the amount of GTP left 
in the reaction after incubation (see Materials and Methods). I observed that in this in vitro 
GTP hydrolysis assay Sar1A hydrolysed GTP in a concentration-dependent manner, as the 
amount of GTP remaining at higher Sar1A concentrations was lower than that remaining at 
lower Sar1A concentrations (Fig. 3.14). I further observed that the addition of the purified 
inner coat components stimulated GTP hydrolysis by Sar1 (Fig. 3.14, compare the orange 
and blue curves). This suggests that the purified Sec23A/24C is capable of binding Sar1A.  
In this experiment, I did not measure the maximal luminescence for each reaction condition 
in the absence of Sar1-dependent GTP hydrolysis. In future experiments, each reaction 
condition was also performed in the absence of Sar1 to allow for the normalisation of 
fluorescence measurements in different reaction conditions. 
 
   
 
 




Figure 3.14: Nickel affinity-purified Sar1A hydrolyses GTP in an in vitro GTP hydrolysis assay, 
and its activity is stimulated by the inner coat components. A range of concentrations of 
Sar1A were incubated with GTP in the presence or absence of inner coat components, and 
the amount of GTP remaining in the reaction was measured. The error bars represent 
standard deviation.  
 
After I established that nickel affinity-purified Sar1A was capable of hydrolysing GTP, I set 
out to assess its membrane binding efficiency. In liposome flotation experiments, I 
concluded that Sar1A purified by nickel affinity purification was incapable of binding 
membranes. I changed purification strategy and purified Sar1A and Sar1B using glutathione 
affinity purification. After I established that glutathione affinity-purified Sar1 paralogues 
were capable of binding membranes (see Section III.3.), I set out to compare the GTP 
hydrolysis activities of the two Sar1 paralogues.  
First, it was necessary to optimise the concentration range of Sar1 paralogues used in the 
reaction, such that the highest concentration of Sar1 used fully hydrolyses the GTP present 
in the reaction in the total reaction time. As a starting point, I measured GTP hydrolysis by 
Sar1A and Sar1B at a concentration range up to 5µM (Fig.  3.15). The measured values for 
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the amount of GTP remaining in the reaction following incubation were normalised to the 
GTP signal obtained in the absence of any GTP hydrolysis by Sar1. This was measured by 
performing control reactions in the absence of Sar1. I observed that both Sar1A and Sar1B 
purified by glutathione affinity have an intrinsic GTP hydrolysis activity and hydrolyse GTP in 
a concentration-dependent manner (Fig. 3.15).  
 
Figure 3.15:  Initial GTP hydrolysis experiments using the two Sar1 paralogues. In this 
experiment, 5µM of Sar1A hydrolyse 95% of the GTP present in the 30 min reaction time. 
Sar1B at the same concentration hydrolyses 55% of the GTP.  
 
For Sar1A, a concentration range of 0-5µM was well-suited. In this experiment, a 5µM Sar1B 
concentration was insufficient to hydrolyse the amount of GTP present in the reaction in the 
30 min reaction time. Hence, I chose a higher Sar1B concentration range (up to 15µM) and 
the same Sar1A concentration range (up to 5µM) for the comparison of GTP hydrolysis 
between the two proteins. 
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Using these concentration ranges, I compared GTP hydrolysis by the two Sar1 paralogues 
using proteins purified in consecutive purifications following the same protocol, I discovered 
a great extent of variability. 
The same concentration of Sar1A from different purifications hydrolysed different amounts 
of GTP in the same reaction time (Fig 3.16A). The same effect, albeit less pronounced, was 
observed for Sar1B (Fig. 3.16B). When the reaction curves for both paralogues are plotted 
together, it becomes apparent that a direct comparison between the GTPase activities of 
the two paralogues is unavailing, as GTP hydrolysis by Sar1 varies greatly between 




   
 
 




Figure 3.16: Variability in GTP hydrolysis activity between Sar1 proteins purified in separate 
purifications using the same glutathione affinity purification protocol.  
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To assess whether the addition of the other COPII components stimulates Sar1 GTP 
hydrolysis activity, I performed reactions in the presence of the purified inner and outer 
COPII components using the product of a single Sar1 purification for each paralogue. In 
membrane binding experiments, I had established that the inner and outer coat components 
are recruited to membranes at a 320nM concentration (Section III.3.). Hence, I added the 
same concentration of coat components to GTP hydrolysis reactions.  
When reactions were set up with Sar1A in the presence of its GAP Sec23A/24C, more GTP 
was hydrolysed for the same reaction time when compared to reactions containing only 
Sar1A. Even higher amounts of GTP were hydrolysed when reactions were performed in the 
presence of the Sec23A/24C and Sec13/31A, suggesting that inner and outer coat 
components stimulate the GTP hydrolysis activity of Sar1A (Fig. 3.17).  
Figure 3.17: GTP hydrolysis by Sar1A in the presence of the inner coat and outer coat COPII 
components.  
 
When I used the Sar1B paralogue in GTP hydrolysis reactions, addition of the inner coat 
proteins enhanced Sar1B GTP hydrolysis activity, and the outer coat components stimulated 
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Figure 3.18: GTP hydrolysis by Sar1B is stimulated by the addition of the inner coat 
components Sec23A/24C and further stimulated by the addition of the outer coat 
components Sec13/31A. The error bars represent standard deviation.  
 
These results confirm that the human Sar1 paralogues I purified by glutathione affinity 
purification have an intrinsic GTP hydrolysis activity. The GTP hydrolysis activity of Sar1 was 
stimulated by the COPII coat components. The finding that GTP hydrolysis activity varies 
significantly between protein obtained from different purifications calls into question the 
validity of direct comparisons between the GTP hydrolysis rates of the two paralogues using 
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IV. COPII Budding Reactions 
by Electron Microscopy 
 
To analyse human COPII assembled on membranes, I reconstituted the human COPII 
secretion system in vitro using purified proteins and membrane models. I combined 
Sec13/31A and Sec23A/24C purified from insect cells and Sar1 purified from E. coli with GUVs 
in the presence of non-hydrolysable GTP analogues and EDTA and analysed the reactions 
using electron microscopy. Sar1A purified by glutathione affinity purification was capable of 
deforming GUVs in the absence of COPII components, and upon the addition of COPII 
components formed tubules protruding from membrane donors. When I added Sar1B 
purified by glutathione affinity purification to GUVs, I observed concentration-dependent 
membrane deformation. In reactions performed with Sar1B and the other COPII components, 
membrane protrusions displayed a beads-on-a-string morphology. When I analysed 
reconstitution reactions with Sar1B and the other COPII components using cryo-EM, the two 
layers of the assembled human COPII coat were clearly visible on the membrane. 
 
IV.1. In vitro reconstitution of the mammalian COPII secretion system 
 
Studies of the COPII secretion system in vivo and in vitro provide insight into the mechanisms 
that allow for cargo export from the ER. I aimed to establish a minimal in vitro reconstitution 
system for the study of mammalian COPII assemblies. While imposing simplification on the 
study a complex system, in vitro reconstitutions can help unravel the foundation mechanisms 
of COPII assembly in humans. Successfully reconstituting multicomponent molecular systems 
in vitro demonstrates our understanding of the minimal requirements for their formation. 
The reconstituted reactions are well-suited for structural studies as they include only 
components of interest at controlled concentrations. This results in minima0l background 
during imaging and easy identification of components during data processing. Reconstituting 
the COPII secretion system in vitro can also provide a platform for the investigation of COPII 
regulatory proteins, such as Tango1/cTAGE5, by addition to the reconstitution reaction. 
Finally, substituting particular COPII components with their paralogues can facilitate an 
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understanding of their different functions in the context of COPII assembly formation. The 
establishment of a reconstitution system for yeast has been instrumental in our 
understanding of COPII binding, COPII-mediated membrane deformation, and large COPII 
assembly structure (Bacia et al., 2011; Zanetti et al., 2013; Daum et al., 2014; Hutchings et al., 
2018). To establish human COPII in vitro reconstitution reactions, I combined purified core 
COPII components with giant unilamellar vesicles as a membrane model in the presence of 
non-hydrolysable GTP analogue and EDTA. 
IV.1.1. Membrane models 
IV.1.1.1. Lipid composition 
Since Sar1 and Sec23/24 directly interact with the membrane, the lipid composition of the 
membrane influences their recruitment (Matsuoka et al., 1998). Therefore, when the ER 
membrane is substituted by membrane models in in vitro reconstitution experiments, the 
lipid composition of those membrane models should be similar that of the ER and maximise 
binding of COPII components. Furthermore, the remodelling activity of COPII proteins on the 
membrane depends on the biophysical properties of the membrane, such as its charge and 
fluidity (Matsuoka et al., 1998; Marsh, 2006). In cells, the COPII machinery itself can affect the 
membrane lipid composition through its interaction with membrane-remodelling enzymes, 
such as phospholipases; however, the effects of this interplay require further investigation 
(Pathre et al., 2003; Melero et al., 2018). In this work, I have used a major-minor and 
cholesterol lipid mixture. This was based on a major-minor lipid mixture, which was shown to 
maximise yeast COPII binding and recruitment (Introduction, Section I.7.) (Matsuoka et al., 
1998). The components of the major-minor mixture were originally established through 
measurements of the recruitment of purified COPII components to a range of lipids and their 
combinations (Matsuoka et al., 1998). They are further described in the Introduction, Section 
I.7. The addition of cholesterol reflects the presence of cholesterol in mammalian ER 
membranes and mirrors the established use of ergosterol for yeast membrane models (Bacia 
et al., 2011; Zanetti et al., 2013; Daum et al., 2014; Hutchings et al., 2018). Ergosterol does 
not increase COPII binding, but functions to confer appropriate fluidity and rigidity to the 
membrane (Matsuoka et al., 1998). 
Membrane models do not include protein components that reside in the membrane and can 
influence COPII recruitment and action, such as Sec12, the GEF for Sar1 (Barlowe and 
 
   
 
 
  95 
 
 
Schekman, 1993; Weissman, Plutner and Balch, 2001). Following the establishment of a 
minimal reconstitution system, additional protein components can be studied by addition to 
the budding reaction. 
IV.1.1.2. Giant Unilamellar Vesicles 
A range of membrane models are used for in vitro experiments with membrane-binding 
proteins. These vary in their size and their associated curvature. GUVs were chosen based on 
the large surface area they provide for COPII association and budding. GUVs were also used 
in studies of large yeast COPII assemblies. As the diameter of GUVs falls in the micrometre 
range (Fig. 1), using GUVs allowed the visualisation of remodelled membranes as emanating 
from the surface of GUVs. On the contrary, using smaller membrane models, such as 
liposomes, with a diameter similar to the size of COPII vesicles (60-80nm) (Barlowe et al., 
1994; Zeuschner et al., 2006), would not allow for a distinction between COPII-coated 
membrane models and active membrane remodeling events (Bacia et al., 2011).  
A range of different techniques can be used for GUV formation (Morales-Penningston et al., 
2010). I have used electroformation, which involves the coating of opposing 
electroconductive surfaces with lipids and the generation of a current between the surfaces 
(Angelova and Dimitrov, 1986). The GUV electroformation chamber is filled with sucrose. 
Sucrose-filled GUVs are then harvested from the chamber and added to a collection tube filled 
with glucose solution. When incubated overnight, GUVs settle to the bottom of the collection 
tube. With this technique, unilamellar vesicles of sizes between 2 and 10µm are generated, 
as assessed by fluorescence microscopy using Texas Red-labelled PE for visualisation (Fig. 4.1). 
Those are of sufficient density and size to allow for screening of COPII reactions using EM. 
 
   
 
 





Figure 4.1: GUVs, made from a lipid mixture similar 
to the lipid composition of the mammalian ER, as 
visualised by fluorescence microscopy. GUVs 
produced by electroformation form a mixture of 




IV.1.2. Additional reaction components: Non-hydrolysable GTP analogues and EDTA 
Human COPII in vitro reconstitution reactions aim to capture COPII components assembled 
on membranes. As discussed in further detail in Section I.2. of the Introduction, Sar1 projects 
an N-terminal amphipathic helix into the membrane in its active, GTP-bound state and 
recruits the rest of the COPII machinery (Huang et al., 2001; Bielli et al., 2005). However, COPII 
assemblies are transient due to their intrinsic propensity for disassembly upon GTP hydrolysis. 
Disassembly is directly triggered by coat assembly: the inner coat component Sec23 is the 
GAP of Sar1, and its GAP activity is further stimulated by Sec31 (Zanetti et al., 2012). Upon 
GTP hydrolysis, Sar1 sheds from the membrane, which ultimately results in coat disassembly 
(Zanetti et al., 2012). Therefore, to study COPII associated with membranes, we prevent GTP 
hydrolysis by the addition of non-hydrolysable GTP analogues. Alternatively, a GTP hydrolysis-
deficient mutant of Sar1 can be used (Sar1 H79G) which has been established in the literature 
(Bannykh, Rowe and Balch, 1996; Aridor et al., 2001; Bielli et al., 2005).  
Sar1 binding to the non-hydrolysable GTP analogue present in the reaction is essential for 
Sar1 membrane recruitment and COPII membrane retainment. In vivo, the exchange of GDP 
for GTP by Sar1 is facilitated by its essential GEF Sec12 (Nakano, Brada and Schekman, 1988). 
No other functions of Sec12 are essential for COPII vesicle formation in vitro, as pre-
equilibration of Sar1 with GMP-PNP circumvents the requirement for Sec12 in both yeast and 
mammalian reconstitution reactions (Matsuoka et al., 1998; Bacia et al., 2011; Hariri et al., 
2014; Hutchings et al., 2018). For yeast, it has been established that EDTA can substitute for 
Sec12 in in vitro reconstitution reactions (Bacia et al., 2011). The mechanism of the 
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substitution of the native GEF with EDTA requires further investigation in the case of Sar1 but 
has been well established for other GTP-binding proteins (Zhang et al., 2000). EDTA is a cation 
chelating agent, which lowers the concentration of available divalent cations in solution, 
including Mg2+, hence affecting the turnover of bound Mg2+. The structure of human Sar1A in 
complex with GDP reveals magnesium coordination of nucleotide binding, similarly to 
previously released structures of yeast and hamster Sar1 (human Sar1A - PDB ID 2GAO, 
hamster Sar1 – PDB ID 1F6B, yeast Sar1 – PDB ID 1M20). A structure of hamster Sar1 obtained 
at a low (1mM) Mg2+concentration reveals that one of its regulatory switches, switch 1, moves 
to an open conformation in the absence of Mg2+ (Rao et al., 2006). For GTPases from the Ras 
superfamily, which Sar1 belongs to, it has been shown that Mg2+ release results in a 50 to 
100-fold decrease in nucleotide affinity (Hall and Self, 1986; Klebe et al., 1995). This allows 
for GDP disassociation. The low nucleotide affinity can then be overcome in vitro by using a 
high non-hydrolysable GTP analogue concentration (in this work 1mM), and the presence of 
Mg2+ in the solution in the budding reaction buffer (in this work HKM, see Materials and 
Methods). 
A comparison between the use of Sec12 and EDTA for nucleotide exchange has suggested 
that both enable the same morphological effect on GUV membranes in the presence of GMP-
PNP and yeast COPII components (Bacia et al., 2011). Aiming to minimise the number of 
protein components to include in in vitro reconstitutions, I used 2.5mM EDTA in budding 
reactions and did not include Sec12.  
IV.2. Electron microscopy of budding reactions using Sar1A purified by 
nickel affinity purification 
 
IV.2.1. Sar1A deforms membranes in the absence of the other COPII components 
I first purified Sar1A by nickel affinity purification (Biochemical Analysis of Human COPII 
Assembly on Membranes, Section III.3) and aimed to characterise the optimal concentration 
of Sar1A to use in budding reactions. As discussed in the Introduction, Section I.5.1.1, Sar1A 
is capable of deforming membranes in the absence of other COPII components. The ability of 
GTP-locked mammalian Sar1 to generate constrictions on membranes independent of the 
rest of the COPII machinery has been described and characterised previously (Long et al., 
2010; Hariri et al., 2014). I tested the membrane-deforming activity of a range of Sar1A 
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concentrations by adding Sar1A to GUVs in the absence of other COPII components. Reactions 
contained GTPjS and EDTA, allowing for stable Sar1A membrane binding. GDP was used 
instead of GTPjS in negative control reactions. Reactions were assessed by negative stain EM. 
To date, we have not established a quantitative measure of budding frequency and rely on 
visual assessment. To assess budding efficiency, I observed GUVs to assess vesiculation and 
tubulation emanating from the donors.  
I screened a low micromolar range of Sar1A concentrations (0.7µM-3.4µM), informed by the 
use of similar concentrations for COPII reconstitution reactions with yeast Sar1. At a Sar1A 
concentration of 0.7µM in GTPjS reactions, GUVs were not deformed. When Sar1A 
concentration was increased to 1.7µM, few GUVs were deformed, and membranes formed 
small, connected vesicles ≈30-40nm in diameter (Fig. 4.2). This suggested that Sar1A is 
sufficient for the generation of curvature on membrane models and that Sar1A membrane 
deformation is concentration-dependent. However, the efficiency of membrane remodeling 




   
 
 





Figure 4.2: Sar1A, purified by nickel affinity purification, generates connected vesiculations 
and tubulations emanating from GUVs, as observed using negative stain EM. 1.7µM Sar1A 
was added to GUVs in the presence of 1mM GTPjS and 2.5mM EDTA.  
 
IV.2.2. COPII components deform membranes, but do not form a coat 
To reconstitute the COPII coat bound to GUVs, I added COPII components to GUVs in the 
presence of GTPjS and EDTA. I tested a range of concentrations of nickel affinity purified 
Sar1A (0.7µM-3.4µM) and analysed budding efficiency and membrane morphology (Fig. 4.3). 
The concentration of other COPII components was constant. As a starting point, I tested an 
80nM Sec23A/24C concentration and a 130nM Sec13/31A concentration. The ratio between 
inner and outer coat components was as used previously in yeast in vitro reconstitution 
experiments (Zanetti et al., 2013). 
 
   
 
 





Figure 4.3: The addition of Sar1A, purified by nickel affinity purification, and COPII 
components to GUVs results in membrane deformation, as observed using negative stain EM. 
A range of concentrations of Sar1A (0.7µM-3.4µM) and COPII components were added to 
GUVs. Budding frequency increased with Sar1 concentration, and membrane protrusions 
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became shorter and more disorderly. (A) 0.7µM Sar1A, 80nM Sec23A/24C, and 130nM 
Sec13/31A were incubated with GUVs, in the presence of 1mM GTPjS and 2.5mM EDTA. (B) 
1.7µM Sar1A, 80nM Sec23A/24C, and 130nM Sec13/31A were incubated with GUVs in the 
presence of 1mM GTPjS and 2.5mM EDTA. (C) 3.4µM Sar1A, 80nM Sec23A/24C, and 130nM 
Sec13/31A were incubated with GUVs in the presence of 1mM GTPjS and 2.5mM EDTA. 
 
I observed that the incubation of GUVs with COPII proteins generated membrane curvature 
and two main morphologies – vesiculations and tubulations, similarly to reactions performed 
with Sar1 in the absence of other COPII components (Fig. 4.3). I further observed that 
increasing the concentration of Sar1A increased the incidence of budding events. By visual 
inspection, GUVs budded more with 1.7µM Sar1A (Fig. 4.3A) than with 0.7µM Sar1A (Fig. 
4.3B), and more often when 3.4µM Sar1A was used (Fig. 4.3C). Furthermore, increasing the 
concentration of Sar1A to 3.4µM visibly decreased the length and increased the ‘disorder’ of 
membrane protrusions (Fig. 4.3C). 
To assess whether the COPII coat was assembling on membranes, I compared the diameter 
of vesiculations generated by Sar1A alone and by Sar1A in the presence of the inner and outer 
coat components. In the literature, Sar1-induced membrane protrusions from membrane 
models have been reported with a variety of sizes. Upon addition to liposomes and giant 
unilamellar vesicles, yeast Sar1 forms tubules of  a ≈26nm diameter (Lee et al., 2005; Bacia et 
al., 2011). This is similar to tubules formed by the addition of hamster Sar1 to large unilamellar 
vesicles (LUVs), which were measured at ≈22nm (Long et al., 2010). On GUVs, the addition of 
hamster Sar1 produced two kinds of tubes: flexible tubes of a 30-60nm diameter, and rigid 
tubules wider than 40nm (Long et al., 2010).  
In yeast, vesicles and tubes formed by the full COPII coat are larger than those formed by Sar1 
alone. Vesicles formed in the presence of all yeast COPII components measure 60-80nm in 
diameter (Barlowe et al., 1994), while yeast COPII tubes are around 80nm in diameter (Zanetti 
et al., 2013). I therefore expected that vesiculations formed in the presence of COPII 
components would have a generally larger diameter than Sar1-only deformations due to the 
size of the COPII coat. I measured the diameter of the vesicles using ImageJ software. As 
vesicles were not perfectly circular, the largest vesicle diameter was used. Unexpectedly, I 
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observed that vesicle diameters were not significantly different: 32nm for Sar1A-only vesicles 
and 33nm for COPII-formed vesicles, with standard deviations of 6.4nm and 6.9nm, 
respectively (Fig. 4.4). This suggested that COPII components were not forming a stable coat 
on the membrane, or that their binding did not change the size of the vesicles as assessed by 

















Figure 4.4: Vesiculations formed upon the addition of His-purified Sar1A only (A) and upon 
the addition of all COPII components (B) are of similar sizes. Reactions consisted of GUVs, 
2.5mM EDTA, 1mM GTPjS, 1.7µM Sar1A in the absence (A) or presence (B) of 80nM 
Sec23A/24C and 130nM Sec13/31A. Diameters of the vesiculations as analysed by negative 
stain EM were measured using ImageJ software. 
 
   
 
 










As a positive control for COPII-mediated 
membrane deformation experiments, I set up 
in vitro reconstitution reactions using yeast 
COPII proteins and GUVs (Fig. 4.5). This was 
done using yeast proteins purified by 
J.Hutchings in-house at the following 
concentrations: 1µM Sar1, 320nM Sec23/24, 
and 173nM Sec13/31. Reactions were 
screened by negative-stain EM.  
 
Tubular protrusions from GUVs were observed 
in this experiment, suggesting that COPII 








Figure 4.5: Yeast in vitro reconstitutions show tubular protrusions emanating from GUVs. 
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Hypothesising that higher COPII component concentrations could result in COPII membrane 
coating, I increased the concentration of COPII components I added in budding reactions. I 
added Sec23A/24C to a 320nM concentration, and Sec13/31A to a 520nM concentration, as 
previously used in yeast in vitro reconstitutions (Zanetti et al., 2013). I found that the general 
morphology or size of the vesiculations did not change (compare Fig. 4.6 to Fig. 4.3).  
 
Figure 4.6: Increasing the concentration of COPII components does not alter the general 
morphology. Vesiculations and tubulations were observed protruding from GUVs. 1µM Sar1A, 
320nM Sec23A/24C, 520nM Sec13/31A were added to GUVs in the presence of 1mM GTPγS 
and 2.5mM EDTA. 
 
Aiming to assess whether COPII components were binding membranes, I tested the 
recruitment of COPII components to the liposomes using liposome flotation assays (see 
Biochemical Analysis of Human COPII Assembly on Membranes, Section III.3.). Liposomes are 
an appropriate membrane model for this assay as they are stable enough to allow for the 
centrifugation that separates the membrane-bound floating fraction from the unbound 
protein fraction. From these experiments, I concluded that COPII components were not being 
stably recruited. This prompted an optimisation of COPII binding to membranes, importantly 
an optimisation of the Sar1 construct and purification strategy, as described in Biochemical 
Analysis of Human COPII Assembly on Membranes, Section III.2.3. 
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IV.3. Sar1 paralogues purified by glutathione affinity purification 
deform membranes and recruit the COPII coat 
 
Binding of the Sar1 GTPase to liposomes was optimised as described in Biochemical Analysis 
of Human COPII Assembly on Membranes, Section III.3. I showed that Sar1 paralogues purified 
by glutathione affinity purification are efficient in binding membranes and recruiting COPII 
components. Therefore, I used Sar1 paralogues purified by glutathione affinity in subsequent 
budding reactions. 
IV.3.1. Sar1A  
 
To assess membrane deformation by Sar1A in the absence of other COPII components, I 
added Sar1A purified by glutathione affinity purification to GUVs. When I added 1µM of 
Sar1A, I did not observe any visible deformation of GUVs (Fig. 4.7A). I then set out to assess 
whether a higher Sar1A concentration is capable of deforming membrane donors. At the 
higher protein concentration of 8µM Sar1A, I saw vesicular (4.7B) and tubular (4.7C) 
protrusions emanating from GUVs. Vesiculations were of a similar size and appearance to 
those generated by nickel affinity-purified Sar1A (see Section IV.2.). Tubules had a smooth 
appearance, bearing resemblance to tubules observed previously with hamster Sar1 from 
large unilamellar vesicles (LUVs) (Long et al., 2010). However, they were wider, measuring 
80nm in diameter, as opposed to 30-60nm for those generated by hamster Sar1 on LUVs 
(Long et al., 2010). 
 
 
   
 
 





Figure 4.7: Sar1A, purified by glutathione affinity purification, generates vesiculations and 
tubulations from GUVs, as seen using negative stain EM. (A) 1µM Sar1A was added to GUVs. 
(B) 8µM Sar1A was added to GUVs. No membrane deformation by Sar1A is observed at 1µM 
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Sar1A. At an 8µM concentration, Sar1A formed vesiculations and tubulations emanating from 
membrane donors. 
I then set out to assess membrane deformation by Sar1A and the other COPII components. 
When I added 1µM Sar1A to GUVs in the presence of purified Sec23A/24C and Sec13/31A, I 
observed tubes of 80-90nm diameter emanating from membrane donors (Fig. 4.8). Tubules 
were strongly contrasted to the background of the negative stain.  
  
 
Figure 4.8: Sar1A, purified by glutathione 
affinity purification, generates tubules 
emanating from membrane models in the 
presence of 320nM Sec23A/24C and 320nM 




Since the diameter of tubules formed by Sar1A in the presence and absence of additional 
COPII components are comparable, it is possible that COPII components are not recruited to 
Sar1A-coated membranes. Alternatively, tubules could be collapsing under the negative stain, 
if they lack rigidity (Asadi et al., 2017). To assess whether Sar1A is efficiently recruiting COPII 
components to membranes, membrane binding assays can be used, similarly to those that 
confirmed that Sar1B recruits COPII components to membranes (Biochemical Analysis of 
COPII Assembly on Membranes, Section III.3.). 
IV.3.2. Sar1B 
IV.3.2.1. Sar1B deforms liposomes and recruits COPII components to assemble a coat 
After confirming that Sar1B purified by glutathione affinity purification binds liposomes and 
recruits COPII components, I visualised this binding using negative stain EM. Upon the 
addition of Sar1B to liposomes, the majority of liposomes were deformed, and vesicular and 
tubular protrusions from liposomes were observed (Figure 4.9A). These were similar in 
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appearance to membrane deformations generated by nickel affinity-purified Sar1 (see 
Section IV.2). The vesiculations had a diameter of 20-30nm, while tubular protrusions had a 
diameter of 15-25nm. The diameter of the tubular protrusions is consistent with tubules 
previously observed by hamster Sar1 on LUVs (Long et al., 2010). When all COPII components 
were added, coated vesicles of 70-80nm were seen, suggesting that COPII membrane 
recruitment resulted in COPII coat polymerisation (Figure 4.9B).   
 
Figure 4.9: Sar1B, purified by glutathione affinity purification, (A) binds and deforms 
liposomes and (B) recruits the COPII components to coat vesicles, as seen using negative stain 
EM. (A) 1µM Sar1B was added to liposomes in the presence of 1mM GMP-PNP and 2.5mM 
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EDTA. (B) 1µM Sar1B, 320nM Sec23A/24C, and 320nM Sec13/31A were added to liposomes 
with 1mM GMP-PNP and 2.5mM EDTA. 
IV.3.2.2. Sar1B deforms GUVs into tubules 
I assessed the effect of Sar1B addition to GUVs in budding reactions containing GMP-PNP and 
EDTA. A range of Sar1B concentrations between 0.25µM and 8µM were tested, and reactions 
were observed using negative stain EM.   
Sar1B deformed vesicles in a concentration-dependent manner (Fig. 4.10). At a 0.25µM Sar1B 
concentration, no membrane deformation was observed (Fig. 4.10A). At a 1µM 
concentration, while most GUVs remained unperturbed, long tubules projecting from some 
GUVs became visible (Fig. 10B). When the concentration was increased to 8µM, the majority 
of vesicles were deformed and tubes emanating from GUVs were widespread (Fig. 4.10C). 
The tubular protrusions had a wide range of diameters, ranging from 30 to 75nm. The 
diameters changed along the length of single tubes, suggesting that they were not defined by 
a regular protein lattice. These observations indicated that Sar1B efficiently binds membranes 
of lower curvature, such as GUVs, and not only membranes of higher curvature, such as 
liposomes, as established in liposome binding experiments. 
 
   
 
 





Figure 4.10: Sar1B, purified by glutathione affinity purification, generates tubulations 
emanating from GUVs, as seen using negative stain EM. Increasing the Sar1B concentrations 
 
   
 
 
  111 
 
 
results in an increase in tubule formation. (A) 0.25µM Sar1B was added to GUVs in the 
presence of 1mM GMP-PNP and 2.5mM EDTA. (B) 1µM Sar1B was added. (C) 8µM Sar1B was 
added. 
 
To observe COPII bound to membranes, a 1µM Sar1B concentration was selected for future 
budding reactions, identical to the concentration used in liposome flotation assays. This 
concentration was chosen to allow for efficient membrane binding while avoiding extensive 
deformation due to Sar1 alone.  
IV.3.2.3. COPII deforms GUVs and forms coated vesiculations 
To observe COPII membrane binding, 1µM Sar1B, 320nM Sec23A/24C, and 320nM Sec13/31A 
were added to GUVs. Inner and outer coat concentrations were equal to those used in 
liposome flotation reactions. Reactions included 1mM GMP-PNP and 2.5mM EDTA and were 
assessed by negative stain EM.  
Membrane deformation was widespread in these reactions (Fig 4.11), compared to reactions 
using only Sar1B at 1µM (Fig. 4.10). This suggests that inner and outer coat COPII components 
actively participate in remodelling membranes. Furthermore, a beads-on-a-string 
morphology was observed, with beads with an average size of 70nm. This differs from the 
tubular protrusions generated by Sar1B alone, demonstrating that COPII components define 
membrane curvature when Sar1B is used in budding reactions.  
 
   
 
 




Figure 4.11: Sar1B, purified by glutathione affinity purification, and COPII components form 
connected vesiculations emanating from GUVs, as seen using negative stain EM. 1µM Sar1B, 
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320nM Sec23A/24C, and 320nM Sec13/31A were added to GUVs with 1mM GMP-PNP and 
2.5mM EDTA.  
 
As I observed that COPII components were recruited to GUVs and were efficiently 
polymerising, I proceeded to analyse the reactions using cryo-EM. While negative stain EM is 
well-suited for assessing membrane deformation and optimising reactions, it cannot be used 
to obtain high-resolution information. In negative stain EM, the sample is surrounded by an 
envelope of the stain used for sample preparation, and the resolution is limited by the grain 
size of the stain (Kiselev, Sherman and Tsuprun, 1990; Scarff et al., 2018). Furthermore, the 
sample is imaged in the non-native environment of the stain. In cryo-EM, the sample is 
maintained in its native environment prior to freezing, and high-resolution structural 
information can be obtained. Hence, I prepared vitrified samples of COPII reactions for cryo-
EM. 
Cryo-EM analysis of COPII reactions revealed pleomorphic membrane deformations 
resembling strings of vesicles with clearly discernible membrane, inner coat, and outer coat 
layers (Fig. 4.12). To analyse the position of the human COPII coat layers in respect to each 
other and the membrane, a small set of particles (n=288) were manually selected from 
electron micrographs using e2boxer in eman2 (Fig. 4.13A and B) (Tang et al., 2007). These 
particles were imported into Relion 3.1 and classified into two classes to allow for a separation 
between true particles and junk particles (Fig. 4.13C) (Scheres, 2012). The first class contained 
72% of particles (n=207), and in this class average three layers are clearly visible: the 
membrane layer, the inner coat, and the outer coat (Fig. 4.13C). To generate a density profile, 
the grey values along a line perpendicular to the membrane were obtained from the class 
average (Fig. 4.13D). In the density profile, three clear peaks can be distinguished, 
corresponding to the outer coat, inner coat, and membrane layers (Fig. 4.13E). The two 
membrane leaflets produced a single peak in the density profile and cannot be distinguished. 
The distance between the outer and inner coat layers was »35 pixels, equal to 94Å. The 
distance between the inner coat and the membrane was 70Å (26 pixels). These distances are 
comparable to those observed for yeast as measured from a low-resolution average of yeast 
COPII assembled on membranes: for yeast, the distance between the inner and the outer coat 
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was 91Å, while the distance between the inner coat and the middle of the membrane was 
57Å (Hutchings et al., 2020; Zanetti, G., personal communication). 
 
Figure 4.12: COPII 
components added to 
GUVs form layers of COPII 
coat on the membrane, as 
seen using cryo-EM. 
Reactions contained 1µM 
Sar1B,  320nM 
Sec23A/24C, and 320nM 
Sec13/31A, which were 
added to GUVs in the 
presence of 1mM GMP-
PNP and 2.5mM EDTA.
  
 
While the observed membrane morphology is irregular and obtaining high-resolution 
structural information would pose a challenge, the collection of cryo-tomography data of 
these reactions and analysis using subtomogram averaging could provide low-resolution 
information about the interfaces that allow for inner and outer coat formation. 
 
   
 
 




Figure 4.13: Density profile analysis of human COPII assembled on membranes. A small set of 
particles was selected from electron micrographs (Fig. 4.13A and B) and classified into two 
classes (Fig. 4.13C). In the average of the first class, (Fig. 4.13C, left-hand side), three layers 
were clearly visible, corresponding to the membrane, inner, and outer COPII coat. The second 
class (Fig. 4.12C, right-hand side) was used to separate ‘junk’ particles. 
The intensities of these layers were measured using a line (red) perpendicular to the 
membrane (Fig. 4.13D). In the density profile, these layers were represented by clear peaks 
(Fig. 4.12E). Pixel size: 2.678Å.  
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V. Discussion and Future 
Directions  
 
The COPII secretion system is an essential and highly conserved vesicular trafficking system, 
which has evolved significant complexity to meet the transport demands of the cells of higher 
eukaryotes. This work describes the establishment of an in vitro reconstitution platform for 
the study of human COPII assembled on membranes. Establishing this platform enables us to 
address outstanding questions about the functioning of this trafficking system in humans: do 
human COPII components remodel membranes to enable cargo export? What are the 
minimal requirements for human COPII-dependent membrane remodelling? What is the role 
of GTP hydrolysis in membrane deformation and vesicle scission? Why are mutations in Sar1B, 
and not Sar1A, implicated in human disease? 
Multiple hypotheses have been proposed about the role of mammalian COPII in the export 
of cargo. Whether mammalian COPII proteins deform the ER membrane to form carriers has 
been the subject of debate, crucially because there is a lack of clarity on how COPII carriers 
can accommodate the demands of the mammalian cell, particularly regarding the export of 
large cargo (Fromme and Schekman, 2005). As COPII components are nonetheless essential 
for cargo export, they have alternatively been proposed to organise ER exit sites and 
concentrate cargo but not deform and coat membranes to enable cargo trafficking (Stephens 
and Pepperkok, 2001, 2002; Mironov et al., 2003; Siddiqi, 2003; Palmer and Stephens, 2004).  
In vivo, regulatory components such as Tango1/cTAGE5 are necessary for the export of large 
cargo (Saito et al., 2009; Wilson et al., 2011; Ma and Goldberg, 2016; Maeda, Katada and 
Saito, 2017; Raote et al., 2018). The precise role of these regulatory components in the 
generation of mammalian COPII carriers has been investigated in biochemical studies. It has 
been proposed that the ER membrane-resident Tango1 enables the generation of tubular 
protrusions from the ER by binding the inner COPII coat, outcompeting the outer coat COPII 
components (Ma and Goldberg, 2016; Raote et al., 2018). This would restrict the outer COPII 
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coat to ER-distal part of the growing COPII carrier. In this view, Tango1 is essential for the 
generation of tubular membrane morphologies. In a recent pre-print article, McCaughey et 
al. use fluorescence and electron microscopy of various Tango1 knock-out cell lines to show 
that in the absence of Tango1 the ERGIC is disrupted and the number of small COPII vesicles 
increases. They propose that in mammalian cells which express Tango1-family proteins COPII 
is inhibited from forming spherical vesicles. They further suggest that Tango1 promotes 
formation of tubular-vesicular clusters that form the ERGIC, essentially suggesting that in the 
absence of Tango1 the mammalian secretory pathway defaults to resemble that of yeast 
(McCaughey et al., 2021). 
Three potential roles of COPII in cargo export from the ER are shown in Figure 5: 
1. COPII does not sculpt membranes and plays an indirect role in cargo export from the ER, 
such as organising ER exit sites and concentrating cargo (Fig. 5.1A). 
2. COPII sculpts membranes to form small vesicles for the export of small cargo. However, 
COPII proteins do not participate in the formation of large cargo export carriers (Fig. 
5.1B). 
3. COPII sculpts membranes to form vesicles and, supported by large cargo adapters, forms 
large carriers for the export of a wide range of cargo from the ER (Fig. 5.1C).  
 
This study has shown that COPII proteins sculpt membranes to form strings of connected 
vesicles (‘beads-on-a-string’), suggesting that COPII components are capable of forming 
vesicles for cargo export. The connectedness between vesicles likely reflects the absence of 
vesicle scission in the absence of GTP hydrolysis. To further to establish that human COPII 
proteins can form isolated vesicles for cargo export, a budding reconstitution using native 
ER membranes and purified proteins in the presence of GTP can be performed. In these 
conditions, COPII vesicles should bud from the donor membrane and separate during 
centrifugation.  
As for the role of COPII in large cargo export and whether COPII can shape the membrane to 
accommodate large cargo, this study shows that a range of curvatures can be generated by 
addition of COPII to membranes. However, beads-on-a-string’ morphologies were most 
widespread upon addition of Sar1B and the other COPII components to membranes, 
suggesting that COPII tends to form more spherical vesicles. This work is therefore consistent 
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with the notion that additional factors, such as Tango1/cTAGE, are required to form 
elongated membrane protrusions as appropriate for the export of large cargo. The precise 
role of COPII in the sculpting of these carriers is unclear.  
 
Figure 5.1: Models for the role of COPII in cargo export from the human ER. (A) COPII 
components function only to organise ER exit sites and concentrate cargo. (B) COPII 
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components form vesicles for the export of small cargo from the ER, but are not involved in 
large cargo export. (C) COPII components form small cargo vesicles and participate in the 
formation of larger carriers.  
 
Using cryo-EM, I clearly observed the layers of the human COPII coat for the first time. 
Establishing this in vitro reconstitution system is therefore the first step towards the structural 
analysis of human COPII assemblies on membranes. Studying in vitro reconstituted human 
COPII assemblies using cryo-electron tomography and subtomogram averaging can provide 
insight into the intermolecular contacts that govern human COPII assembly and the 
mechanism of membrane curvature generation. Using this in vitro reconstitution platform, 
the structural rationale for the presence of different inner and outer COPII coat component 
paralogues can be studied by substitution with different paralogues in budding reactions.  
The key to the establishment of this in vitro reconstitution platform was the optimisation of 
the construct design and purification procedure for human Sar1 to produce protein that was 
efficient in membrane binding. I produced Sar1 using three alternative Sar1 purification 
strategies, N-terminal and C-terminal His-nickel affinity and N-terminal His-glutathione 
affinity. Only glutathione affinity purification produced Sar1 that bound liposomes (Fig. 3.12). 
Since the amino acid sequences of Sar1 produced by N-terminal His-nickel affinity and N-
terminal GST-glutathione affinity were identical, their differences in membrane binding could 
be caused by differences in conformation or oligomerisation state. Previous studies have 
identified the ability of mammalian Sar1 to self-oligomerise (Huang et al., 2001; Hariri et al., 
2014; Hanna et al., 2016). To enable structural determination of hamster Sar1A by X-ray 
crystallography, the N-terminus of Sar1A was truncated, and the authors suggested that full-
length Sar1A is not suitable for crystal formation as it forms higher-order assemblies (Huang 
et al., 2001). The oligomeric status of human Sar1B has also been assessed in previous work, 
and Sar1B was shown to exist in a mixture of monomeric and oligomeric states (Hanna et al., 
2016). Hence, it is possible that the Sar1 I purified using nickel affinity purification was forming 
oligomers in solution and was hence not capable of membrane binding. Two main differences 
between the two purification protocols can potentially result in different oligomeric states. 
First, the GST-tag on Sar1 for glutathione affinity purification is larger than the His-tag for 
nickel affinity purification. It is possible that, prior to the GST-tag cleavage, the size of the tag 
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inhibits the close association of Sar1 molecules through steric hindrance. Second, during the 
cleavage step of the GST-tag, GDP was added in the glutathione affinity purification. GDP was 
and not added at any point during the nickel affinity purification protocol. How the nucleotide 
state of Sar1 affects its oligomerisation state remains to be experimentally established. 
However, GTP binding by Sar1 is proposed to induce a conformational change on Sar1 and 
result in the protrusion of its N-terminal amphipathic helix (Goldberg, 1998; Huang et al., 
2001; Bi, Corpina and Goldberg, 2002; Bielli et al., 2005; Rao et al., 2006; Hutchings et al., 
2018). It is therefore expected that N-terminal helix of Sar1 is less exposed in a GDP-bound 
state. As the N-terminal helix of Sar1 has been implicated in Sar1 oligomerisation (Huang et 
al., 2001), it is possible that GDP binding prevents the formation of higher-order Sar1 
oligomers. 
While the formation of higher-order oligomers in solution in the absence of membranes could 
prevent subsequent membrane association, Sar1 oligomerisation on membranes could serve 
a functional purpose. In the crystal structure of hamster Sar1A, the protein is assembled in 
dimers (Huang et al., 2001). Dimerisation of Sar1A was also observed in samples of human 
Sar1A associated with membranes (Hariri et al., 2014). In these samples, Sar1A formed locally 
ordered arrays of dimers that enabled the generation of membrane curvature in the absence 
of other COPII components. 
I optimised and characterised the human COPII secretion system by focusing on three aspects: 
measuring the GTP hydrolysis activity of Sar1 and its stimulation by the other coat 
components, assessing the membrane binding of Sar1 and recruitment of other coat 
components, and analysing COPII reconstitution reactions by electron microscopy. 
Importantly, investigating these aspects was central to characterising the differences 
between the two Sar1 paralogues. 
The role of GTP hydrolysis by Sar1 in membrane deformation and fission has been the subject 
of multiple investigations, and it has been suggested that GTP hydrolysis is needed for 
membrane remodelling by mammalian Sar1 (Hanna et al., 2016). This work suggests that Sar1 
can remodel membranes in the absence of GTP hydrolysis as incubated with non-hydrolysable 
GTP analogues. Furthermore, membrane deformations emanating from GUVs remained 
associated with the donor vesicles, suggesting that GTP hydrolysis is necessary for membrane 
fission, as observed previously for mammalian cells (Bannykh, Rowe and Balch, 1996).  
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Importantly, by measuring GTP hydrolysis activity, I set out to analyse the differences 
between Sar1A and Sar1B. Sar1B has been specifically implicated in human diseases caused 
by large cargo transport deficits (Jones et al., 2003). There are multiple lines of evidence that 
suggest that large carrier formation is enabled by delayed GTP hydrolysis (Antonny et al., 
2001; Saito et al., 2009; Malhotra and Erlmann, 2011). Hence, studies aiming to understand 
differences between two paralogues have investigated the differences in their GTP hydrolysis 
rates. Using in vitro GTP hydrolysis assays, I confirm that both Sar1A and Sar1B have an 
intrinsic GTP hydrolysis activity. The GTP hydrolysis rates I measured varied between proteins 
produced in different purifications, hence comparisons between the GTP hydrolysis rates of 
the two purified protein paralogues remained uninformative. The inner and outer coat 
components stimulated GTP hydrolysis activity by Sar1, as expected (Fromme et al., 2007; 
Melville, Studer and Schekman, 2020), suggesting that the purified proteins are capable of 
functional binding.  
In this work, in addition to assessing Sar1 GTP hydrolysis and comparing GTP hydrolysis 
activities between Sar1 paralogues, I investigated their membrane binding capability in the 
presence of GTP analogues and GDP. Membrane recruitment of the two paralogues has not 
been compared previously.  
When I assessed the membrane binding of the two paralogues in liposome flotation 
experiments, I observed that Sar1A was recruited to liposomes equally with GMP-PNP and 
GDP, while Sar1B was recruited more efficiently with GMP-PNP than with GDP. These results 
for Sar1A are in line with a previous study that assessed liposome binding of hamster Sar1A 
in the presence of GTP analogues and GDP (Kim et al., 2005). For human Sar1B, it has 
previously been suggested that the N-terminal amphipathic helix that mediates membrane 
binding is solvent-exposed both with GTP and GDP, but that GTP binding results in more stable 
membrane association (Hanna et al., 2016). The observation that the nucleotide state of 
Sar1B affects the efficiency of its recruitment to membranes suggests that Sar1B can be 
regulated by the local GTP levels at ERES. Regulation of Sar1B membrane binding is necessary 
in the context of large carrier generation: the formation of large carriers needs to be coupled 
to the presence of large cargo at particular ER loci.  
I compared the membrane morphologies induced by Sar1A and Sar1B, which have not been 
observed previously. When I assessed membrane deformation by Sar1 paralogues by 
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negative stain EM in the absence of other coat components, I observed that Sar1A formed 
vesiculations and smooth wide tubules emanating from GUVs, while Sar1B produced irregular 
tubules. When COPII components were added to Sar1B reactions with GUVs, membrane 
morphology was different to that observed with Sar1B alone, suggesting that COPII 
components dictated the morphology of membrane deformations. These reactions 
predominantly contained connected membrane vesicles, in contrast with yeast, where the 
incubation of COPII components with GUVs in the presence of a non-hydrolysable GTP 
analogue results in ordered tubes emanating from GUVs (Bacia et al., 2011; Zanetti et al., 
2013; Hutchings et al., 2018). It remains unclear how the vesicular membrane deformation 
generated by Sar1B and COPII components can be modulated to accommodate large cargo. 
In vivo, the generation of large COPII carriers requires the large cargo adapters 
Tango1/cTAGE5 which reside in the ER membrane and potentially compete with the outer 
coat for inner coat binding (Ma and Goldberg, 2016). Hence, it is possible that the membrane 
morphologies I observe as dictated by inner and outer COPII coats in the presence of Sar1B 
are more relevant at ER-distal curved carrier tips, while more ER-proximal morphologies are 
dictated by Tango1/cTAGE5.  
In addition to investigating overall morphology, I observed COPII binding to membranes using 
cryo-electron microscopy. I observed the human COPII coat assembled on the membrane in 
two clearly discernible layers, similarly to what has been observed for in vitro human COPII 
assemblies in the absence of membrane (Stagg et al., 2008) and with yeast proteins 
assembled on membranes (Bacia et al., 2011; Zanetti et al., 2013; Hutchings et al., 2018).  
While using a minimal reconstitution system can help address fundamental questions about 
the human COPII secretion system, this minimalistic approach is also a simplification of a 
complex system and hence poses limitations. Reconstitutions exclude protein and lipid 
components that impact COPII function in vivo. In fact, while this in vitro reconstitution 
included the five core COPII proteins, proteomic analysis of COPII vesicles derived from 
human immortalised cells has identified 60 different proteins, which were all components of 
the early secretory pathway (Adolf et al., 2019). While the role of some additional protein 
components in the COPIII vesicle formation remains to be investigated, COPII interacting 
partners such as Sec12 and Sec16 have been well-established as regulators of COPII function 
(Nakano, Brada and Schekman, 1988; Barlowe et al., 1994; Weissman, Plutner and Balch, 
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2001; Supek et al., 2002; Bielli et al., 2005; Watson et al., 2006). Including these factors in in 
vitro reconstitution reactions can be a tool for studying the complexity of the regulatory 
network of COPII assembly. While additional purified cytosolic factors, such as Sec16, can be 
directly added to budding reactions, the incorporation of transmembrane proteins, such as 
Sec12 and the large cargo adapters Tango1/cTAGE5, into model membranes remains 
challenging. Apart from the interaction of specific protein components with the core COPII 
machinery, the absence of protein components in lipid models has implications for 
membrane deformability. 
In this work, in vitro reconstitutions were performed in the absence of cargo. It has been 
established that the presence of cargo decreases membrane deformability (Čopič et al., 2012; 
D’Arcangelo et al., 2015; Gomez-Navarro et al., 2020; Stancheva et al., 2020). It has previously 
been shown that purified mammalian COPII components that bind artificial membranes in 
vitro are incapable of remodelling microsomes (ER-derived membrane vesicles) in the 
absence of additional cytosolic factors (Kim et al., 2005). Therefore, while I showed that the 
minimal set of COPII components is sufficient for membrane deformation of GUVs, it remains 
to be established whether this mix of purified COPII components can deform cargo-loaded 
membranes, or whether additional factors are needed. Reconstituting COPII budding from 
microsomes can help gain biologically relevant insight into COPII-mediated deformation of 
cargo-loaded membranes. 
The lipid composition of the membrane models I used to reconstitute the human COPII 
system was based on a lipid mixture optimised to maximise yeast COPII components 
(Matsuoka et al., 1998). However, this lipid mixture is not identical to the lipid composition 
of the ER in mammals, as it excludes lipids that are present in the ER in considerable 
amounts, such as sphingomyelin and ceramides (Vance, 2015). Furthermore, it includes 
lipids such as PI4P, which are commonly absent from the ER, which implies that observed 
membrane deformation effects can be non-physiological (Vance, 2015). The lipid mixture 
has also not been specifically optimised to maximise human COPII binding. Additionally, 
recent lipidomic analysis investigated the lipid composition of yeast cell-derived COPII 
vesicles and established an enrichment of specific lipids compared to the membrane of the 
ER  (Melero et al., 2018). These lysophospholipids were shown to enhance COPII membrane 
recruitment and increase membrane fluidity. Further human COPII in vitro reconstitution 
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can benefit from reflecting the membrane composition established in human cell lipidomic 
studies, including specific lipid proportions, in membrane models. Finally, the Sar1 GTPase 
has been shown to dynamically interact with the local membrane composition. Sar1 
enhances the activity of phospholipases, and it has been demonstrated that in vivo COPII 
export is blocked by phospholipase inhibition (Bi, Roth and Ktistakis, 1997; Pathre et al., 
2003; Shimoi et al., 2005). Hence, COPII components can moderate ER lipid composition, 
and this dynamic regulation has functional importance. While such effects are not reflected 
in in vitro reconstitutions, they can impact membrane deformability and COPII binding.  
As GTP hydrolysis results in COPII membrane dissociation, to retain COPII components on 
membranes, I utilised non-hydrolysable GTP analogues. While stable COPII membrane 
association is essential for structural studies, observing COPII proteins in the act of 
remodeling membranes in the presence of GTP hydrolysis can help unravel the dynamics of 
this complex system.  
In conclusion, this thesis describes the establishment of an in vitro reconstitution platform for 
the human COPII secretion system. I show that purified core human COPII components bind 
membranes and are sufficient for the deformation of membrane models. Using cryo-EM, I 
obtained the first images of human COPII assembled on membranes and show that human 
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